rfhg_178627.1

Basic information about the TSS

---

TSS ID: rfhg_178627.1 Species: human Chr: chr15		Start: 96330784 End: 96330813 Strand: +
Source datasets	DRA013844|PRJNA4843412
Protocol	CAGE|NETCAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2829122,EH38E1790959)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC042897:-67 GeneID: 7026 HGNC/MGI_ID: HGNC:7976 UniProt_ID: Nearer transcript ids and distances: M62760:69 ENST00000394166.8:-84 NM_021005.4:-84 view more...

Gene_name: nuclear receptor subfamily 2 group F member 2 Gene_symbol: NR2F2 Gene_synonyms: COUP-TFII COUPTF2 COUPTFB NF-E3 SVP40 Gene_source: HGNC:7976

TATA-Box annotation

---

Distance to TSS:	98
Nearest PromoterID:	NM_021005
Entrez ID:	7026
Nearest Unigene:	Hs.347991
Nearest Refseq:	NM_021005
Nearest Ensembl:	ENSG00000185551
Gene Name:	nuclear receptor subfamily 2 group F member 2
Gene Alias:	ARP-1|ARP1|CHTD4|COUPTF2|COUPTFB|COUPTFII|NF-E3|SVP40|TFCOUP2
Gene Type:	protein-coding
CpG%:	0.068966
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NR2F2 p2@NR2F2 p3@NR2F2 p4@NR2F2 p5@NR2F2 p6@NR2F2 p7@NR2F2 p8@NR2F2 p9@NR2F2 p10@NR2F2
Sample		p1@NR2F2	p2@NR2F2	p3@NR2F2	p4@NR2F2	p5@NR2F2	p6@NR2F2	p7@NR2F2	p8@NR2F2	p9@NR2F2	p10@NR2F2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	40.13	19.87	9.55	35.26	7.79	0.00	3.51	4.09	3.12	2.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.41	19.83	6.88	26.50	7.69	0.20	1.62	6.68	3.03	3.44
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	41.47	24.11	6.94	26.81	9.84	0.19	2.89	3.67	2.12	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	34.31	20.38	7.28	22.87	6.65	0.21	2.91	2.08	5.61	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.09	17.10	5.62	28.35	9.00	0.00	4.05	4.27	4.05	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	38.57	22.68	7.17	26.75	9.69	0.19	3.29	4.85	3.68	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	23.75	12.20	3.49	11.77	5.45	0.00	0.87	3.05	3.05	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	26.89	13.32	4.84	19.38	4.84	0.00	1.70	1.70	3.63	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.24	12.18	4.06	18.17	4.49	0.00	1.07	2.99	1.71	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	23.19	11.01	4.06	22.61	11.59	0.58	1.74	1.74	4.64	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.02	8.89	4.45	22.64	9.30	0.00	2.43	1.21	4.45	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	10.16	6.91	19.51	7.32	0.41	1.63	4.07	4.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	110.09	65.61	62.06	14.18	4.03	3.06	5.96	6.61	2.42	6.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	108.10	51.87	58.79	10.07	2.56	3.31	5.86	4.81	2.10	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	107.14	54.67	53.13	11.64	2.85	1.76	4.17	2.85	2.20	5.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	109.90	63.88	72.43	9.31	2.77	2.26	5.03	5.53	1.76	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	98.50	58.53	62.46	10.05	4.15	1.97	3.06	3.06	2.40	5.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	100.39	45.56	69.60	11.81	1.69	3.37	5.06	10.97	2.53	10.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	84.24	58.65	51.18	10.13	2.67	2.13	2.13	5.33	1.60	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	94.18	50.70	48.74	10.23	2.86	3.16	5.57	3.61	2.11	4.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	82.06	38.63	43.17	11.23	3.88	1.74	3.61	4.14	2.00	4.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	84.59	39.19	41.60	11.74	2.59	3.11	3.80	2.93	1.73	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	70.83	40.97	41.88	7.37	2.33	2.59	2.71	2.97	1.03	5.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	74.74	43.44	47.08	8.25	2.43	2.43	3.88	5.58	1.46	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	79.46	38.18	40.76	9.80	3.10	3.10	3.10	4.13	0.52	3.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	54.44	33.55	32.92	9.18	1.58	1.58	2.85	3.17	1.58	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	80.77	37.36	45.06	7.69	2.75	0.55	4.95	5.49	1.65	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	61.53	30.18	29.47	6.84	1.65	0.24	3.30	2.83	0.94	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	43.13	19.22	20.35	7.43	2.26	1.78	2.75	2.10	1.29	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	52.30	25.88	25.34	6.51	1.63	2.53	1.45	1.81	0.72	4.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	33.70	16.54	19.68	7.75	1.47	1.26	1.67	1.47	0.63	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	38.69	16.22	20.12	6.06	1.95	1.37	0.78	2.54	0.78	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.93	13.72	16.04	5.91	0.84	1.48	1.48	2.74	1.06	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.45	9.90	13.85	7.59	0.66	1.48	1.48	1.32	1.15	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	30.29	11.22	14.77	6.36	0.93	1.12	1.68	1.12	0.56	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.08	12.65	11.31	5.75	2.11	0.38	0.96	2.30	0.19	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	39.45	9.61	10.83	8.99	0.20	0.61	1.23	1.02	0.61	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.83	8.87	10.88	7.05	0.00	1.81	1.41	2.22	1.21	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	32.68	5.94	11.34	6.75	0.27	0.81	1.08	1.89	0.54	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.93	6.96	10.56	6.48	0.72	0.96	0.72	1.68	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	40.70	7.76	10.59	6.82	1.18	0.24	1.18	1.88	0.94	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	40.26	7.91	7.17	10.25	1.46	1.32	0.73	1.61	0.59	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	48.93	8.22	13.50	10.97	1.05	1.27	0.84	1.69	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	47.20	9.44	12.59	9.27	1.75	0.87	0.70	1.75	0.70	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	40.76	8.83	9.24	7.23	1.61	0.60	0.80	2.01	0.60	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	42.34	9.54	9.07	6.75	0.23	0.47	0.93	1.63	0.93	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	53.02	10.56	14.87	10.32	0.24	0.48	0.48	2.16	0.72	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.49	7.75	8.35	4.77	0.60	0.60	0.30	1.19	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.91	6.46	5.03	5.74	0.96	0.72	0.00	0.48	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.04	6.07	6.67	4.45	0.81	1.01	1.21	0.61	0.40	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	28.69	9.02	13.94	11.68	0.61	0.61	0.20	0.61	0.82	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	23.13	4.00	6.89	8.45	0.89	0.67	0.22	1.33	0.44	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	0.00	13.99	13.99	0.00	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.90	3.19	7.81	6.74	0.00	0.35	0.00	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	7.29	5.63	5.63	0.66	0.33	0.66	0.00	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	23.49	5.03	15.10	4.19	0.00	0.84	0.00	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	5.97	4.13	7.35	0.00	1.84	0.46	0.92	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.96	11.99	13.61	8.75	0.00	0.32	0.32	1.62	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.02	6.10	8.99	6.42	0.32	0.32	0.32	1.28	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	37.09	6.60	11.00	14.77	0.31	0.63	0.00	1.57	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	2.82	9.17	3.53	0.00	1.41	0.00	1.41	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.14	5.61	7.29	4.49	0.00	1.12	0.56	1.12	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	42.99	5.57	9.55	19.11	0.00	0.00	0.00	4.78	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.52	4.08	8.15	13.93	0.34	0.00	0.34	1.70	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	30.22	8.77	14.62	13.32	0.00	0.65	0.32	1.95	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.97	6.74	7.81	11.71	0.35	1.06	0.71	1.42	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	15.79	31.59	0.00	0.00	7.90	0.00	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	8.78	7.80	6.34	0.98	0.00	0.49	2.93	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.88	8.93	6.94	7.44	0.00	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.20	8.91	10.79	4.69	0.00	0.47	0.00	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.78	31.79	17.22	15.57	0.99	1.99	0.00	1.99	0.00	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.34	30.01	25.68	6.81	0.62	0.93	0.00	0.62	0.62	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.76	17.73	17.12	7.95	0.00	0.92	0.00	0.92	0.31	1.22
Adipocyte - breast, donor1	11376-118A8	100.26	64.62	50.84	9.98	14.73	15.84	18.06	6.81	3.01	4.59
Adipocyte - breast, donor2	11327-117E4	45.72	24.06	36.10	6.90	4.33	3.69	8.02	4.65	0.80	3.05
Adipocyte - omental, donor1	11473-119C6	125.19	85.37	65.39	10.94	18.83	24.55	27.61	8.40	3.05	7.63
Adipocyte - omental, donor2	11474-119C7	41.86	23.92	25.41	5.98	1.49	2.99	3.74	5.23	1.49	3.74
Adipocyte - omental, donor3	11475-119C8	65.98	56.27	60.29	2.01	10.72	14.74	12.73	11.72	1.67	2.34
Adipocyte - perirenal, donor1	11476-119C9	52.95	38.28	29.35	6.38	3.83	15.95	7.66	10.21	1.91	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	4.40	0.00	0.00	1.10	1.10	1.10	0.00	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	24.84	12.19	8.58	6.32	4.52	0.90	4.97	0.45	0.45	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	11.99	5.73	6.26	4.00	0.70	0.00	1.39	0.17	0.00	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	24.84	4.69	6.65	9.19	1.56	0.00	1.56	10.76	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	10.30	2.57	5.15	4.38	0.26	0.00	0.26	0.26	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	11.99	2.51	3.90	5.02	0.56	0.00	1.12	0.28	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	18.22	2.35	5.88	7.64	1.18	0.00	0.00	0.00	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	22.36	5.71	14.08	7.72	0.16	0.00	0.72	0.48	0.56	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	4.84	20.01	6.46	0.32	0.00	0.97	1.29	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	13.33	2.13	17.06	6.93	1.60	0.00	0.00	0.53	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	18.36	2.23	14.47	3.34	0.00	0.00	1.11	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	10.81	3.33	7.49	2.50	0.42	0.00	0.83	0.00	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	13.56	3.52	13.06	4.77	0.25	0.00	0.00	0.50	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	16.04	3.27	9.49	5.24	0.33	0.00	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.27	4.26	13.09	3.04	0.00	0.00	0.61	1.22	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	47.51	10.39	11.49	9.50	0.88	2.21	0.66	0.88	3.09	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	17.57	5.74	4.30	4.66	1.79	0.36	1.08	0.72	0.72	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	8.39	10.78	3.59	1.20	0.00	0.00	3.59	2.40	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	37.96	9.89	3.60	18.53	5.22	5.58	1.26	0.90	5.94	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	6.69	8.37	18.41	8.37	5.02	0.00	1.67	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	37.39	8.42	7.19	10.68	3.08	7.60	1.23	0.82	2.88	0.62
Anulus Pulposus Cell, donor1	11248-116E6	18.88	6.06	3.55	8.01	1.14	1.37	0.57	0.69	0.80	0.80
Anulus Pulposus Cell, donor2	11463-119B5	19.84	6.12	5.14	5.14	2.20	0.73	0.49	1.71	1.47	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	13.48	7.64	5.39	6.74	6.29	2.70	3.59	0.90	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.56	10.42	6.08	6.95	6.08	7.38	3.91	2.60	1.30	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	10.70	8.56	4.28	0.00	10.70	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.90	12.26	8.37	5.98	6.58	3.59	2.69	4.18	1.20	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	35.41	10.12	13.91	3.79	7.59	1.26	3.79	5.06	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	21.12	11.22	8.58	1.98	2.64	5.28	1.98	2.64	1.98	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.84	13.65	7.15	3.90	4.87	3.57	2.92	4.87	0.65	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.64	13.11	7.77	6.31	5.83	5.83	1.94	6.31	1.46	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.85	11.88	8.91	5.94	4.75	5.94	1.19	4.16	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.61	14.31	9.04	9.42	4.90	6.40	1.51	2.26	0.38	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	25.40	10.89	10.16	7.26	5.08	8.71	2.18	3.63	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	11.28	10.03	5.02	3.76	5.02	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	25.70	10.71	5.27	5.77	6.10	6.42	2.47	0.33	1.81	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	10.92	1.36	9.55	1.36	1.36	2.73	2.73	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.48	10.10	7.24	9.50	3.92	4.37	1.21	0.75	0.45	1.96
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	38.58	13.93	7.50	4.82	4.29	10.18	6.43	5.36	0.54	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	32.31	15.11	8.69	8.31	5.86	5.48	3.21	4.35	2.27	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	30.20	13.63	13.10	6.41	6.68	5.88	2.14	6.41	1.87	2.41
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	37.07	12.68	7.80	9.75	4.88	5.85	4.88	1.95	0.00	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	32.18	14.26	8.62	7.13	5.47	5.31	3.32	4.31	0.33	2.65
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	20.41	6.00	9.61	7.20	6.00	4.80	2.40	2.40	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	17.70	7.08	3.54	7.08	10.62	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	31.05	14.07	9.61	6.00	4.29	6.18	2.92	3.60	0.86	2.74
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	12.58	12.58	8.39	0.00	8.39	8.39	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	26.70	16.99	9.22	8.74	9.22	8.74	2.43	4.85	0.97	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.77	12.90	7.97	8.35	7.21	8.73	2.28	4.93	1.52	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	13.33	7.27	3.63	1.21	4.85	3.63	3.63	1.21	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	20.52	13.11	13.68	10.26	3.42	7.98	1.71	2.85	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.94	14.96	7.48	6.20	6.84	7.05	4.49	4.06	1.07	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.84	13.42	11.61	6.71	3.36	6.97	2.06	2.32	0.52	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	25.81	7.51	10.32	6.10	2.82	7.04	1.41	3.28	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.51	9.00	6.43	6.43	6.11	6.11	1.29	2.57	0.64	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	25.68	11.42	4.99	5.71	3.57	9.99	2.14	0.71	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	21.64	8.19	7.02	4.68	7.02	4.09	3.51	2.34	0.00	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.00	12.04	8.13	8.73	6.02	10.54	3.01	4.52	0.60	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	29.70	17.82	8.32	2.38	4.75	5.94	0.00	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.89	12.21	7.63	7.63	6.61	3.56	1.53	3.05	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	25.72	12.23	8.66	7.64	5.86	6.62	1.27	3.06	1.02	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.33	8.26	6.99	3.18	4.45	3.81	1.27	0.64	1.27	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.56	10.36	5.61	4.32	6.04	6.04	3.45	1.73	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.04	13.76	7.62	6.14	3.81	7.20	2.96	3.39	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.08	7.83	7.25	3.19	4.35	5.51	2.32	1.74	1.16	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	15.12	5.67	3.78	6.61	2.83	3.78	1.89	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.00	9.32	6.78	3.90	5.09	6.44	3.39	2.54	0.85	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	6.95	4.63	4.63	6.95	6.95	2.32	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	10.56	12.68	2.11	2.11	2.11	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	19.08	6.86	7.72	6.22	3.00	5.15	3.65	1.72	0.86	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.06	11.43	5.41	9.02	4.81	5.41	0.60	2.41	1.20	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	5.10	2.92	6.56	0.73	2.92	2.19	2.92	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.16	8.97	7.59	6.21	3.68	5.06	2.76	1.15	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	20.40	10.20	0.00	0.00	2.55	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.02	7.12	3.31	6.86	3.05	2.29	0.00	1.53	0.76	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	21.68	9.29	7.02	4.54	4.75	3.10	2.68	2.48	1.45	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.30	8.87	7.65	6.43	4.59	2.75	1.84	0.92	1.22	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.42	10.52	6.21	9.08	1.91	3.35	0.96	3.82	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.18	11.09	6.43	6.43	1.77	2.66	1.77	2.66	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	6.10	6.10	3.05	3.05	6.10	0.00	3.05	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.19	9.42	6.09	6.09	2.22	2.77	2.77	2.77	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.39	9.53	6.62	5.56	3.71	3.18	0.79	2.12	0.79	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.08	10.18	6.18	4.72	4.00	2.18	1.09	0.36	0.73	1.82
Astrocyte - cerebellum, donor1	11500-119F6	73.94	28.49	23.46	16.83	3.19	1.35	2.58	4.30	5.04	2.21
Astrocyte - cerebellum, donor2	11580-120F5	82.16	29.61	33.89	9.58	3.59	3.42	3.25	7.53	2.05	2.74
Astrocyte - cerebellum, donor3	11661-122F5	30.20	9.23	12.79	6.71	1.05	0.00	1.89	0.84	2.10	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	9.06	0.70	2.09	3.49	0.70	1.39	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	6.96	1.94	3.40	1.29	0.65	0.65	0.65	0.65	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	8.80	3.58	2.98	3.58	0.30	1.04	0.60	0.30	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	43.35	6.31	7.34	25.46	0.69	0.69	0.57	1.38	2.29	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	39.21	7.02	5.01	23.30	0.88	0.88	0.63	1.38	3.51	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	37.78	5.80	4.44	23.44	1.48	0.91	0.68	1.02	2.84	0.91
Basophils, donor1	12241-129G9	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	0.00	0.36	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	4.70	0.73	1.18	1.62	0.15	0.29	0.29	6.91	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	26.95	8.62	6.68	9.06	1.72	3.45	0.43	0.86	1.29	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	21.94	8.69	9.14	5.94	0.46	0.46	0.46	2.74	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	21.52	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	4.39	6.90	3.14	0.00	1.26	0.00	0.63	2.51	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.35	4.78	3.12	4.37	0.21	0.42	1.04	0.21	1.46	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	1.84	2.07	3.22	0.00	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	16.38	9.54	8.46	5.76	0.54	0.54	0.00	1.98	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.18	0.18	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.74	2.46	8.60	2.87	0.00	0.41	0.00	5.32	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1.13	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	0.23	0.23	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	2.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.90	0.00	0.45	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.36	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.00	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.00	0.24	0.00	0.00	0.00	0.24	0.00	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.00	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.00	0.00	0.00	0.00	0.00	0.80	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	116.98	76.77	40.21	16.45	1.83	9.14	1.83	10.97	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	23.22	4.94	6.42	10.87	0.99	0.00	0.00	1.48	1.98	0.99
Cardiac Myocyte, donor3	11686-122I3	24.31	10.52	7.47	6.73	2.32	2.21	2.00	0.74	0.84	1.05
Chondrocyte - de diff, donor1	11261-116G1	2.08	0.00	0.00	3.12	0.00	0.00	0.00	0.69	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	3.20	1.07	0.00	6.04	0.00	0.00	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	1.59	0.46	0.23	1.59	0.23	0.00	0.11	0.23	0.11	0.23
Chondrocyte - re diff, donor2	11339-117F7	7.16	0.00	0.00	12.53	0.00	0.00	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	2.02	0.00	1.21	2.02	0.00	0.40	0.81	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	57.84	15.72	12.05	16.41	2.18	4.48	1.15	2.41	2.98	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	38.69	11.12	13.68	11.12	3.42	5.56	2.78	1.71	2.14	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	48.85	13.27	13.10	9.29	2.04	5.04	2.04	1.42	1.86	1.86
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	144.70	34.39	44.84	18.98	2.93	10.82	4.49	3.12	3.76	1.83
Corneal Epithelial Cells, donor1	11526-119I5	25.03	9.00	7.25	9.66	1.54	1.54	0.44	0.88	0.44	0.88
Corneal Epithelial Cells, donor2	11606-120I4	29.58	6.83	7.96	11.38	2.28	7.96	0.00	1.14	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	26.07	9.97	6.90	5.88	2.30	2.56	0.26	1.53	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	69.71	19.85	12.51	9.17	3.84	1.00	2.84	2.33	4.17	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	49.88	19.36	10.56	5.87	2.93	1.17	2.93	1.76	3.52	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	115.95	26.58	16.69	25.17	4.81	1.41	5.09	2.83	4.52	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	92.40	38.53	23.98	9.44	10.62	1.97	7.86	2.36	3.54	0.79
Endothelial Cells - Artery, donor1	11264-116G4	92.79	35.78	27.34	12.80	6.40	0.87	5.53	1.75	5.24	2.62
Endothelial Cells - Artery, donor2	11341-117F9	65.88	20.23	17.65	11.29	2.59	0.00	1.18	2.12	4.00	3.06
Endothelial Cells - Artery, donor3	11413-118E9	48.74	14.38	13.15	9.99	2.80	0.88	2.10	0.70	2.98	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	100.41	36.57	32.80	10.20	3.99	3.99	3.77	2.66	2.66	2.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	107.41	44.12	34.69	14.30	7.91	4.87	3.65	2.13	1.83	5.78
Endothelial Cells - Lymphatic, donor3	11393-118C7	90.21	33.55	25.94	16.07	3.38	1.41	3.10	2.54	2.54	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	67.75	30.90	17.23	11.89	7.73	0.59	4.75	9.21	2.97	2.67
Endothelial Cells - Microvascular, donor2	11342-117G1	46.86	25.51	9.37	4.17	7.81	0.00	3.64	1.04	0.52	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	47.92	24.81	28.50	7.80	3.83	0.14	3.40	2.69	0.85	1.99
Endothelial Cells - Thoracic, donor1	11266-116G6	182.05	75.22	49.21	19.61	10.00	2.00	8.40	18.41	7.60	4.40
Endothelial Cells - Thoracic, donor2	11343-117G2	40.36	10.48	17.82	9.43	4.19	0.00	2.10	3.14	1.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	233.46	60.63	67.22	30.07	6.34	1.86	8.57	5.96	8.82	3.85
Endothelial Cells - Umbilical vein, donor2	11324-117E1	198.79	61.70	94.73	22.60	5.43	1.09	5.43	3.04	5.65	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	169.88	37.98	58.50	21.37	5.01	1.10	3.54	2.44	6.72	1.71
Endothelial Cells - Vein, donor1	11267-116G7	38.68	19.34	13.65	11.38	2.28	3.41	1.14	1.14	7.96	1.14
Endothelial Cells - Vein, donor2	11344-117G3	72.64	15.37	14.67	16.07	4.19	1.40	3.49	0.70	3.49	0.70
Endothelial Cells - Vein, donor3	11416-118F3	68.46	22.14	20.25	9.89	3.61	0.79	2.83	1.41	2.51	0.63
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	25.17	10.99	9.53	7.82	0.49	0.73	0.49	0.49	1.22	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	24.96	6.24	10.40	2.08	0.00	0.00	0.00	4.16	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	67.73	25.86	20.12	12.73	4.52	4.52	4.11	3.28	0.82	4.11
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.67	8.21	6.57	4.38	1.75	1.31	1.64	1.09	0.44	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	47.45	16.36	27.08	13.43	1.41	3.68	2.17	3.58	1.95	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	60.28	18.19	16.01	13.95	4.97	7.16	5.09	2.43	2.55	1.82
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	25.79	10.24	3.41	6.69	4.50	4.50	2.05	0.82	1.09	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.63	6.64	10.13	7.59	2.95	4.11	3.06	1.90	0.74	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	44.53	16.07	16.86	11.33	5.01	5.53	5.01	8.43	1.58	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	46.84	17.27	20.26	9.97	3.32	5.32	4.65	4.98	1.99	1.66
Fibroblast - Cardiac, donor1	11268-116G8	34.93	8.17	14.06	8.62	2.72	5.44	2.72	1.36	1.81	1.81
Fibroblast - Cardiac, donor2	11345-117G4	13.64	6.06	2.27	6.82	1.52	0.00	0.76	2.27	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	15.93	1.89	2.05	8.36	1.58	1.89	0.79	0.47	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	86.39	35.77	20.01	18.19	6.97	3.03	5.46	1.52	4.55	3.03
Fibroblast - Cardiac, donor5	11456-119A7	41.37	14.34	13.32	8.63	2.92	0.25	2.28	2.28	1.14	1.27
Fibroblast - Cardiac, donor6	11460-119B2	53.21	19.10	22.59	6.97	3.79	1.06	0.91	2.88	3.18	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	196.56	64.32	58.55	21.30	11.39	11.26	9.65	9.38	8.17	5.63
Fibroblast - Choroid Plexus, donor2	11572-120E6	154.45	57.38	62.99	18.12	11.22	9.06	12.51	7.33	2.59	4.31
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	24.90	35.16	10.25	0.00	2.93	0.00	4.39	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	60.89	25.37	14.99	13.61	4.38	3.23	3.23	0.46	1.38	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	66.65	41.55	49.52	10.52	8.65	2.20	4.07	3.73	1.19	5.26
Fibroblast - Dermal, donor1	11269-116G9	33.81	17.84	8.69	6.34	5.87	4.23	7.98	3.05	2.35	2.82
Fibroblast - Dermal, donor2	11346-117G5	45.75	18.40	8.96	10.85	4.72	1.42	3.30	1.42	2.83	2.83
Fibroblast - Dermal, donor3	11418-118F5	44.37	28.17	22.73	8.34	8.95	3.51	8.22	3.26	1.33	3.99
Fibroblast - Dermal, donor4	11450-119A1	25.32	13.45	10.51	6.56	1.13	0.79	0.57	1.47	0.79	1.13
Fibroblast - Dermal, donor5	11454-119A5	15.18	7.15	3.84	4.88	0.52	0.00	0.52	0.87	0.70	1.05
Fibroblast - Dermal, donor6	11458-119A9	15.92	8.12	5.36	7.80	0.97	0.16	0.49	1.62	0.97	0.97
Fibroblast - Gingival, donor1	11237-116D4	39.56	13.95	12.91	12.49	3.54	1.46	2.29	0.62	1.67	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	40.09	9.69	13.10	19.39	1.05	2.62	3.41	2.62	3.41	2.36
Fibroblast - Gingival, donor2	11318-117D4	22.93	7.38	9.49	7.64	0.79	1.05	1.45	1.05	1.05	0.66
Fibroblast - Gingival, donor3	11394-118C8	44.57	21.95	17.98	11.51	4.64	1.06	3.29	1.45	1.64	2.22
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	10.39	1.04	1.04	9.35	0.00	0.00	1.04	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.31	3.88	8.46	11.10	0.18	0.88	0.88	2.29	0.53	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.43	13.72	12.47	9.98	2.65	1.56	1.56	1.25	2.18	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.63	4.33	3.92	9.47	0.95	0.27	1.08	1.22	1.35	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	166.91	45.87	24.35	39.17	13.76	10.59	4.94	3.53	7.06	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.12	12.14	11.85	14.62	0.88	1.90	0.73	2.92	4.24	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.09	5.59	8.04	12.00	1.09	0.68	1.36	0.82	2.73	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	21.61	4.61	6.14	10.75	1.97	0.11	0.44	0.44	1.10	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	11.74	1.47	1.76	12.47	0.15	0.00	1.17	1.03	0.44	0.73
Fibroblast - Lung, donor1	11270-116H1	17.67	21.75	16.31	4.08	1.36	2.72	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	64.16	55.21	19.40	8.95	5.97	4.48	8.95	7.46	2.98	4.48
Fibroblast - Lung, donor3	11419-118F6	63.10	53.18	36.51	7.18	6.54	1.90	8.23	1.48	1.69	4.01
Fibroblast - Lymphatic, donor1	11506-119G3	362.36	210.75	124.12	37.49	26.66	6.66	24.99	19.99	15.83	10.83
Fibroblast - Lymphatic, donor2	11586-120G2	110.49	61.54	60.14	8.39	13.99	1.40	15.38	12.59	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	54.86	27.99	24.07	5.32	8.12	1.40	5.32	0.84	2.52	1.40
Fibroblast - Mammary, donor1	11540-120B1	159.55	62.52	39.38	30.45	6.90	8.93	9.74	0.41	9.34	2.03
Fibroblast - Mammary, donor2	11620-122A9	79.88	35.95	23.97	27.96	0.00	0.00	0.00	0.00	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	47.65	35.74	11.91	11.91	0.00	5.96	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.10	5.04	6.21	7.76	0.00	0.19	0.19	0.58	1.55	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.72	7.43	9.86	5.76	1.67	0.46	0.61	0.76	0.76	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.26	26.31	18.05	16.22	5.20	4.28	3.67	0.61	2.45	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.88	6.11	4.20	8.40	1.14	0.38	0.38	0.00	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.44	4.59	5.40	5.40	0.54	0.54	0.81	1.08	1.89	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	32.59	8.58	9.86	8.35	2.90	0.70	1.86	0.58	0.81	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.44	2.98	3.76	7.74	1.11	1.77	0.99	0.77	1.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	239.36	85.54	62.79	34.95	15.65	22.55	16.46	5.08	19.91	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	14.03	10.69	10.02	2.00	0.67	0.67	2.00	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	32.81	12.65	11.47	4.35	1.58	3.56	1.98	0.79	2.37	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.17	15.28	11.51	12.30	2.58	4.56	1.79	8.73	3.97	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.74	4.09	1.24	13.32	0.71	1.07	0.71	0.36	1.24	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	40.40	14.98	9.07	15.77	1.77	1.97	2.37	2.17	1.97	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	45.43	26.78	15.64	10.83	3.01	8.42	3.31	6.92	3.91	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	81.07	36.16	27.74	18.78	4.43	7.56	2.81	7.99	3.67	3.24
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.77	18.47	8.60	11.89	2.28	6.58	3.04	9.36	1.52	1.77
Fibroblast - skin normal, donor1	11553-120C5	45.78	17.23	6.89	13.13	2.79	3.77	1.80	2.13	1.80	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	26.87	7.42	3.41	13.03	0.60	1.60	1.40	0.60	1.20	0.80
Fibroblast - skin normal, donor2	11561-120D4	15.47	4.32	3.01	10.55	1.00	0.20	0.50	2.41	1.11	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	58.63	19.04	21.16	16.02	2.72	7.25	2.72	9.07	3.32	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	46.06	12.92	9.86	20.88	0.99	3.15	1.16	1.49	1.41	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.34	16.92	15.04	13.85	0.68	0.51	1.20	4.62	0.85	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	6.90	5.58	11.82	2.63	3.61	0.00	3.94	1.31	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	24.61	8.31	4.15	13.63	0.96	3.30	0.75	2.56	1.28	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	52.29	28.51	9.78	13.66	3.37	6.58	1.69	2.02	3.20	1.86
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	43.91	14.58	25.40	8.63	1.10	4.55	0.94	5.02	0.94	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	44.32	0.00	0.00	22.16	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	4.36	7.84	4.36	0.00	0.00	0.87	1.74	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.31	2.25	1.39	6.24	1.73	0.87	0.69	0.35	2.25	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.09	2.86	1.30	9.63	0.78	1.30	0.52	1.04	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.86	2.81	1.79	13.80	0.51	3.58	0.51	0.77	2.04	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	0.00	0.77	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	0.64	0.64	0.00	1.28	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	0.29	0.29	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	268.31	154.15	51.29	99.82	30.06	9.93	28.13	26.20	33.37	72.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	169.42	104.35	46.12	37.67	17.81	6.39	12.56	9.36	10.05	33.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	62.81	45.17	18.03	14.46	3.57	2.38	4.36	5.15	2.38	11.10
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	259.58	151.99	52.34	102.30	28.55	5.29	24.05	23.26	26.70	66.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	152.31	92.95	37.18	37.83	13.05	7.18	12.07	9.13	6.85	32.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	0.00	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.23	2.26	1.27	1.70	0.71	0.28	0.57	0.57	0.42	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	31.28	18.59	8.74	6.03	4.31	1.23	3.20	1.72	0.99	3.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	4.30	1.07	0.81	2.95	0.54	0.00	0.81	0.81	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.85	10.04	3.47	9.17	1.73	0.62	1.36	0.62	1.61	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	10.52	4.15	1.66	4.71	0.28	0.28	0.55	0.28	0.28	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	4.07	0.81	0.41	1.22	0.20	0.20	0.20	2.03	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.73	10.72	5.70	8.67	1.83	0.46	2.51	1.60	1.14	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	8.97	4.48	0.62	3.36	0.62	0.50	0.37	0.37	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	3.93	1.97	0.66	1.97	0.00	0.44	0.44	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	36.34	15.36	7.98	12.11	1.77	2.66	3.84	2.07	0.59	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	26.39	10.65	5.09	11.76	2.07	0.48	1.75	1.11	1.43	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	12.96	3.35	2.01	4.02	0.22	0.22	0.45	1.12	0.45	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.70	15.12	7.06	13.51	1.01	0.60	1.01	2.22	0.81	4.03
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.35	12.04	5.77	12.72	2.37	1.36	1.70	1.70	0.85	2.54
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.50	4.97	2.57	10.73	1.60	1.77	1.42	1.06	1.42	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	82.93	33.30	11.45	34.96	5.93	0.94	4.58	1.98	3.75	6.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	71.56	31.42	7.34	37.91	4.95	0.68	4.27	0.85	3.59	4.95
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	35.63	16.93	6.09	15.05	2.88	0.66	1.99	1.22	0.66	2.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.36	11.23	4.08	13.64	2.00	2.33	1.50	1.00	1.33	2.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.59	11.84	3.27	12.05	2.04	2.04	0.61	1.02	2.04	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.04	14.65	5.98	11.97	2.06	0.41	1.24	2.89	1.03	3.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	36.20	19.72	8.07	16.03	2.19	0.58	2.42	1.96	1.84	3.11
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.51	13.34	3.67	9.17	2.84	0.50	1.00	1.00	1.00	2.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	30.42	12.78	8.16	15.21	1.98	0.66	1.76	2.42	0.44	3.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.94	14.76	6.76	13.16	1.60	0.49	1.23	2.21	0.74	2.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	35.01	13.94	6.00	11.35	1.62	1.46	1.13	0.97	1.13	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	37.52	18.28	7.06	16.36	3.21	0.96	2.89	1.28	1.28	3.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.39	8.81	4.36	9.95	1.52	0.38	1.80	0.47	0.38	1.99
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.92	7.12	3.32	9.33	1.42	0.00	1.11	0.95	0.79	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.98	9.43	2.43	12.16	1.22	0.00	0.91	2.13	0.91	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.13	7.11	3.76	11.50	1.05	0.42	0.63	1.05	1.15	2.40
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.78	8.56	3.51	8.78	1.76	0.00	0.66	1.76	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.86	10.38	5.05	9.26	2.24	0.28	1.40	0.84	0.28	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	12.22	3.61	2.69	8.52	1.30	0.83	1.11	0.28	1.02	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.43	3.74	2.41	9.63	1.87	0.00	0.00	1.07	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.77	4.59	3.52	8.42	1.84	0.61	0.92	1.07	1.84	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.84	3.89	2.98	5.96	0.65	0.13	0.78	0.13	1.04	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.28	6.51	3.25	4.61	1.08	0.27	1.36	0.54	1.08	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	22.31	13.64	5.16	12.35	3.32	0.74	2.21	1.11	1.84	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.47	11.62	5.26	11.18	2.19	0.66	1.54	1.32	1.75	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	63.47	31.74	13.88	37.69	2.98	0.99	4.96	0.00	3.97	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	32.71	15.70	8.84	7.39	5.01	2.77	2.90	1.85	0.66	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.94	19.37	13.52	12.91	4.44	2.02	4.24	3.03	1.21	1.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	140.04	55.41	21.10	63.54	10.17	2.29	9.15	2.03	4.57	6.10
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	0.40	0.40	0.00	0.20	0.00	0.20	0.00	0.60	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	0.62	0.46	0.15	0.77	0.00	0.00	0.00	0.15	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	0.61	0.41	0.00	0.20	0.00	0.00	0.20	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.01	0.31	0.31	1.56	0.31	0.00	0.00	0.94	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.13	0.57	0.00	0.85	0.00	0.00	0.28	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	0.00	0.46	0.46	0.46	0.00	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	4.95	0.00	2.47	0.00	2.47	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	2.32	0.77	0.39	1.55	0.39	0.00	0.00	1.93	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	1.60	0.00	1.60	3.21	0.00	0.00	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	1.74	0.00	0.00	1.74	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.88	1.63	0.65	2.28	0.65	0.65	0.33	1.95	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.47	3.71	0.82	4.12	0.82	0.82	0.82	0.82	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	10.00	6.66	6.66	0.00	3.33	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.42	1.68	1.12	4.19	0.56	1.68	0.84	1.68	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	7.19	1.96	1.96	2.29	0.33	0.65	0.33	1.63	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	14.26	10.07	4.19	7.55	0.84	0.84	0.84	3.36	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.40	6.68	3.82	8.91	2.23	0.95	0.64	2.23	1.27	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.13	2.72	0.00	2.38	0.34	0.68	0.68	1.70	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	4.18	0.00	4.18	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.62	7.45	6.87	10.88	2.86	0.00	2.29	4.01	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.29	5.33	2.07	4.14	0.89	0.30	0.30	2.96	0.89	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	6.78	0.00	5.08	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.50	9.11	2.90	8.70	0.83	1.24	0.41	2.49	1.24	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	22.55	9.44	4.37	10.82	2.53	0.92	2.07	3.45	0.69	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	5.27	0.00	10.54	0.00	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.91	6.92	5.00	13.07	3.08	2.69	1.54	2.69	2.69	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.02	5.87	2.61	8.80	1.96	2.61	0.33	2.28	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	6.69	4.01	8.69	0.67	2.68	2.01	0.67	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	37.37	17.34	8.48	12.33	3.08	2.70	2.70	3.85	1.93	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	32.86	11.30	6.16	18.83	3.42	2.05	1.71	4.45	3.77	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	24.85	9.94	14.91	0.00	0.00	4.97	9.94	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	43.88	32.09	13.21	16.04	2.83	2.36	3.30	5.19	1.42	6.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	27.76	15.69	10.86	15.09	3.02	3.02	4.22	4.83	3.02	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	49.85	20.35	11.19	11.19	5.09	0.00	2.03	1.02	1.02	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.46	27.92	13.16	17.95	1.20	2.39	3.99	6.38	3.99	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	47.86	27.63	18.75	16.28	2.47	1.48	1.48	4.93	3.45	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	43.68	25.97	27.15	22.43	4.72	3.54	3.54	3.54	1.18	10.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	44.34	29.17	12.84	11.09	4.08	2.33	5.25	7.00	0.58	5.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	52.23	32.92	6.58	17.56	2.63	3.51	2.63	7.46	1.76	5.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	14.41	11.87	16.95	0.85	0.85	0.00	4.24	1.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.89	13.13	7.76	10.74	1.79	2.98	2.39	5.37	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	27.17	12.62	7.28	9.70	1.94	3.40	0.97	5.82	0.49	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	0.00	1.14	4.57	0.00	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.72	3.33	3.74	7.07	0.42	0.00	0.42	0.83	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	3.37	1.12	6.75	2.25	1.12	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.15	2.54	2.54	5.07	0.00	0.63	0.00	0.63	0.32	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	3.34	2.92	4.18	0.00	0.42	0.00	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	7.54	2.44	1.39	4.53	1.51	0.12	0.12	0.46	0.35	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	4.56	3.21	1.69	4.56	0.51	0.17	0.68	0.51	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.78	2.73	2.50	3.64	0.68	0.00	0.00	1.14	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.79	3.28	1.31	3.28	1.20	0.00	0.44	0.22	0.22	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.37	0.86	0.43	4.30	0.86	0.00	0.21	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.24	3.23	0.86	2.15	0.65	0.00	0.22	0.22	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.36	2.62	1.12	1.87	0.37	0.00	0.00	0.12	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.74	1.72	1.37	2.23	0.00	0.00	0.17	0.17	0.69	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.88	2.56	0.32	2.56	0.32	0.00	0.00	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	186.35	50.93	67.71	13.99	6.72	1.12	5.60	10.07	6.16	4.48
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	94.35	27.70	24.24	15.58	4.76	0.43	5.19	3.46	4.76	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	89.89	29.08	148.05	21.15	13.22	0.00	5.29	7.93	7.93	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	57.14	18.34	14.81	15.17	4.59	2.82	2.47	0.71	4.23	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	53.04	19.62	22.52	8.72	2.91	4.36	2.18	0.73	2.18	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.55	11.89	14.86	6.99	2.45	1.05	0.70	1.57	2.45	0.87
Hepatocyte, donor1	11523-119I2	44.79	4.84	9.68	15.74	0.00	0.00	0.00	1.21	2.42	1.21
Hepatocyte, donor2	11603-120I1	19.39	3.23	6.46	14.01	0.00	0.00	1.08	4.31	1.08	0.00
Hepatocyte, donor3	11684-122I1	62.58	25.16	53.38	15.95	1.23	0.00	2.45	5.52	1.23	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	75.86	21.67	15.91	13.11	5.24	8.04	2.62	2.45	5.24	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	58.18	24.42	14.82	9.60	4.12	7.68	5.08	3.57	1.92	3.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	6.37	9.55	9.55	3.18	0.00	12.74	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	13.35	6.68	0.00	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	27.08	27.08	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	13.84	0.00	11.08	2.77	0.00	1.38	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	12.51	2.50	2.50	0.00	0.00	2.50	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	23.74	0.00	23.74	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	10.25	12.81	12.81	15.38	0.00	2.56	0.00	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	11.37	14.62	12.99	3.25	0.00	8.12	0.00	4.87	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	3.33	13.34	8.34	5.00	0.00	1.67	1.67	5.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	0.00	14.52	10.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	19.85	2.65	10.59	5.29	0.00	1.32	1.32	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	8.87	4.43	7.76	6.65	0.00	0.00	0.00	1.11	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	10.48	0.00	20.95	0.00	0.00	5.24	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	8.82	8.19	17.01	5.04	0.63	0.63	1.89	3.15	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	6.19	4.64	7.73	3.09	0.00	1.55	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	14.63	29.27	0.00	0.00	0.00	0.00	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.32	10.34	7.11	17.44	3.23	0.00	0.65	3.88	4.52	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	25.76	3.22	20.93	1.61	0.00	0.00	4.83	6.44	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	37.48	16.30	11.41	17.11	4.07	0.81	1.63	1.63	8.96	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	33.17	8.40	2.94	17.21	5.04	0.00	0.84	2.52	2.10	2.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	13.66	7.23	13.66	1.61	1.61	0.00	1.61	7.23	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	25.85	10.16	3.69	10.16	6.46	0.92	0.92	1.85	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	15.08	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.16	7.55	5.19	5.19	2.36	0.47	1.42	1.42	2.36	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	9.07	2.72	10.88	3.63	0.00	0.91	0.91	0.91	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	15.07	7.53	12.91	6.46	2.15	2.15	1.08	7.53	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	12.70	3.81	22.87	8.89	0.00	1.27	0.00	8.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	32.86	0.00	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.78	10.84	6.38	19.77	5.74	1.91	1.28	1.28	2.55	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	10.94	7.29	10.94	5.47	0.00	0.00	1.82	5.47	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	31.61	0.00	47.41	15.80	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	31.42	10.00	7.85	16.42	7.14	1.43	2.14	0.71	8.57	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	9.95	3.32	9.95	6.64	0.00	0.00	0.00	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.21	10.19	3.70	9.57	3.40	0.62	1.23	1.23	2.47	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	10.54	12.29	7.02	5.27	3.51	0.00	1.76	10.54	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	18.86	6.29	12.57	9.43	0.00	0.00	3.14	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.25	13.21	9.04	19.47	4.87	0.00	1.39	0.00	3.48	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	6.64	4.43	13.28	11.07	0.00	0.00	0.00	8.85	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	19.45	3.24	3.24	6.48	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.03	11.34	9.59	16.57	2.62	0.00	0.00	3.49	2.62	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	15.75	2.25	6.75	4.50	0.00	4.50	2.25	4.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	17.42	10.45	17.42	6.97	0.00	0.00	0.00	3.48	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	14.93	11.73	23.47	2.13	0.00	1.07	2.13	5.33	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	18.01	1.39	13.85	9.70	0.00	5.54	1.39	2.77	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	8.55	8.55	5.70	2.85	0.00	2.85	0.00	5.70	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	26.69	21.17	11.97	16.57	6.44	0.00	2.76	1.84	5.52	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	3.03	9.08	12.10	3.03	3.03	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	0.00	18.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	29.61	3.17	5.29	13.75	3.17	0.00	0.00	0.00	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	3.67	0.65	0.33	4.41	0.57	0.49	0.33	0.16	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	4.69	1.17	0.59	3.51	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	11.36	2.84	2.46	6.15	0.28	0.76	0.28	0.76	0.85	0.47
Keratinocyte - oral, donor1	11251-116E9	22.70	8.85	5.79	12.83	2.27	3.75	0.68	1.70	0.79	0.57
Keratocytes, donor1	11527-119I6	33.01	9.28	4.47	12.72	1.38	0.69	0.69	1.38	2.06	0.69
Keratocytes, donor2	11607-120I5	9.37	2.34	1.17	3.52	1.17	0.00	0.00	0.00	3.52	1.17
Keratocytes, donor3	11688-122I5	25.29	15.02	10.28	9.48	2.37	0.00	0.99	2.17	0.40	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	74.73	15.39	0.00	87.92	4.40	0.00	0.00	0.00	10.99	2.20
Lens Epithelial Cells, donor1	11529-119I8	37.76	18.34	17.26	7.55	3.24	6.47	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	32.41	11.99	7.15	10.96	2.42	0.35	0.92	1.27	1.04	1.73
Lens Epithelial Cells, donor3	11690-122I7	41.68	17.26	5.55	12.61	4.34	7.16	3.03	0.71	0.91	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	65.34	35.45	27.75	10.08	3.91	0.36	3.91	2.73	3.79	2.73
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	53.02	23.16	27.91	7.81	4.74	0.56	5.58	6.14	2.79	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	55.57	35.58	37.46	10.70	4.09	0.31	4.25	5.35	2.36	3.46
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.10	24.20	18.28	3.23	3.76	0.00	4.84	3.76	4.84	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	64.61	27.42	27.73	9.45	3.15	0.00	5.04	7.25	2.21	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	41.94	27.28	23.93	4.85	3.13	0.11	3.13	3.02	1.83	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	39.40	22.98	23.39	6.98	7.39	0.00	4.51	5.75	2.05	3.69
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	46.77	26.04	28.82	5.56	4.05	0.51	4.05	2.78	2.28	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	52.92	27.45	30.40	8.30	5.49	0.42	3.10	7.04	1.69	3.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	43.51	22.15	19.38	7.91	5.14	0.00	1.98	3.56	2.77	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	70.57	35.87	36.45	7.56	8.53	0.19	7.76	5.82	5.82	3.10
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	31.85	17.96	14.07	3.89	2.59	0.37	1.67	2.41	0.56	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	44.25	34.49	26.13	6.97	9.41	0.00	2.44	8.01	1.05	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	69.89	33.39	29.10	6.20	5.72	0.24	7.16	4.77	5.49	3.10
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	47.39	21.84	26.92	4.94	3.98	0.14	3.02	4.81	1.92	1.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.96	25.87	18.79	6.78	5.85	0.31	3.70	4.93	2.77	3.39
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	40.84	24.32	24.63	6.55	4.99	0.62	3.12	4.99	3.12	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	63.31	38.79	28.55	6.40	6.22	0.18	4.94	5.12	2.74	4.21
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	45.42	34.89	32.91	7.90	6.58	0.00	5.59	6.25	2.96	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	44.22	25.19	28.41	6.74	2.64	0.59	4.10	2.34	4.39	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.80	28.88	35.10	8.21	3.73	0.75	4.23	4.98	3.24	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	50.44	32.49	31.52	6.30	5.82	0.00	6.30	8.24	3.39	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	60.32	41.47	34.47	5.92	6.73	0.00	7.27	4.58	4.58	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	57.98	37.39	39.66	5.90	6.36	0.45	3.03	6.21	3.63	4.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	38.36	23.33	29.03	7.26	7.26	0.00	2.07	4.15	2.07	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	74.75	41.04	41.67	7.75	8.17	0.21	9.84	5.44	6.28	2.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	50.22	29.17	30.83	5.56	4.36	0.60	4.06	5.56	2.56	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.83	19.95	19.26	7.57	2.75	0.00	4.13	3.44	0.69	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	56.07	28.22	27.09	6.59	6.02	0.56	4.14	3.20	3.39	3.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.43	18.66	25.77	3.39	2.65	0.21	2.01	2.33	1.48	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.77	15.99	23.26	4.36	2.42	0.00	2.42	2.91	3.39	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	52.60	29.11	24.15	5.62	4.63	0.00	4.96	3.31	2.65	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	34.94	19.82	19.82	4.21	2.85	0.12	2.35	3.10	1.98	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	56.64	31.47	26.66	10.00	4.81	0.74	4.44	5.92	2.59	3.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	53.86	25.70	24.21	5.93	5.93	0.25	7.17	4.69	1.98	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	30.52	19.80	18.42	2.89	2.61	0.41	2.89	2.20	2.20	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.20	23.80	23.16	5.15	3.86	0.32	2.25	3.86	0.96	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.30	34.08	29.22	7.91	4.56	0.00	6.09	6.70	3.04	2.74
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	41.15	24.63	22.39	5.88	3.22	0.56	2.38	3.36	2.24	2.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.29	23.11	18.84	6.04	5.33	0.00	2.49	4.27	1.78	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	43.15	27.63	26.18	6.79	4.36	0.48	10.18	5.33	1.45	2.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	31.90	23.03	22.25	4.05	3.89	0.00	3.11	4.05	1.56	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	37.60	18.62	21.13	5.37	3.22	0.00	1.43	3.22	2.15	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	42.14	28.42	22.87	4.90	3.92	0.33	5.23	1.96	2.61	2.61
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	33.43	19.78	19.78	3.53	4.00	0.24	2.83	4.00	1.88	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	62.74	29.33	21.16	12.62	5.32	0.37	3.59	1.73	3.47	2.48
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	38.42	25.36	17.67	6.40	5.12	0.00	3.84	1.79	1.79	2.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	45.95	25.66	25.66	6.56	3.88	0.30	3.28	4.77	1.19	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	79.31	22.66	27.19	6.80	2.27	2.27	6.80	6.80	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	101.26	32.99	36.06	21.48	9.21	1.53	2.30	9.21	3.84	6.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	84.61	28.20	23.01	11.88	5.20	0.74	2.97	1.48	5.20	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	124.40	32.58	39.77	14.39	6.77	3.39	5.92	12.27	2.96	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	94.25	29.54	35.87	10.55	7.03	2.11	2.81	9.14	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	75.65	20.55	24.28	12.14	10.27	2.80	1.87	3.74	1.87	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	98.42	33.49	31.95	11.85	5.67	2.58	5.15	9.79	3.61	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	97.54	30.93	21.41	14.27	5.95	1.19	4.76	1.19	2.38	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	107.22	24.20	15.38	15.38	3.85	2.04	3.62	4.98	2.71	3.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	134.94	45.66	50.31	17.74	11.92	4.94	7.27	13.09	4.36	4.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	141.35	43.22	47.72	14.41	10.35	1.35	4.50	10.80	4.50	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	182.09	40.37	25.61	23.85	9.08	2.03	7.59	5.96	4.47	2.98
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	116.06	42.11	46.73	15.92	7.19	2.05	3.59	13.35	1.54	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	132.67	33.87	34.93	15.17	7.06	3.88	3.88	7.76	2.12	3.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	114.60	31.98	32.65	15.99	8.66	2.67	8.00	8.00	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	127.35	47.37	44.83	18.34	8.66	2.04	6.11	10.70	3.06	6.62
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	140.61	37.09	36.02	21.34	10.14	2.40	7.74	7.74	5.07	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	165.89	39.87	42.70	21.54	10.58	2.65	3.97	14.36	3.40	3.97
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	123.33	43.56	40.50	12.27	6.14	0.61	7.98	7.98	4.91	7.36
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	141.07	35.88	39.14	20.39	6.52	0.82	5.71	8.97	6.52	7.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	154.52	43.94	49.98	21.24	7.71	2.71	6.04	19.99	4.37	3.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	154.42	42.04	47.36	21.86	7.85	3.08	2.80	17.10	4.20	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	147.34	39.15	39.15	15.46	5.15	1.03	4.12	10.30	3.09	9.27
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	167.80	40.64	50.80	21.77	8.42	0.87	5.52	24.97	2.90	5.52
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	114.19	28.40	47.23	14.65	7.47	2.09	1.79	11.36	5.38	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	148.27	38.17	34.30	13.83	9.41	2.77	3.87	7.75	4.43	3.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	154.83	40.30	56.20	24.39	11.31	2.83	4.60	18.73	3.89	6.01
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	133.87	35.40	48.31	14.01	10.33	2.58	2.58	9.22	1.84	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	94.40	21.87	33.39	17.27	4.61	0.00	3.45	11.51	4.61	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	133.93	38.38	50.27	16.50	7.68	1.15	3.84	13.43	3.07	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	142.66	38.50	58.88	17.55	5.10	1.70	4.53	14.15	2.83	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	116.51	34.46	36.10	19.69	9.85	2.46	2.46	3.28	6.56	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	112.52	35.70	57.39	15.82	6.33	0.45	2.26	12.65	4.07	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	121.37	48.12	56.02	15.08	7.18	0.00	2.15	6.46	6.46	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	123.99	39.59	51.54	11.20	12.70	1.49	6.72	11.95	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	132.66	48.31	63.91	15.61	8.92	1.86	6.32	15.61	2.60	6.32
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	110.27	45.23	44.80	13.78	6.46	2.58	1.72	9.48	1.72	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	92.48	42.81	39.39	9.42	8.56	2.57	5.14	3.43	4.28	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	128.61	46.98	66.30	15.66	7.00	1.00	3.33	14.66	4.33	5.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	114.63	45.25	42.23	15.08	4.83	1.21	4.83	9.65	1.81	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	86.03	27.02	34.13	10.66	3.55	3.55	4.98	2.84	2.13	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	123.05	38.84	63.59	19.94	8.25	2.75	7.22	17.87	5.50	3.09
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	104.13	42.94	41.87	16.64	7.51	1.07	3.76	12.88	1.07	5.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	94.27	37.71	35.69	13.47	6.06	2.02	4.71	8.08	6.73	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	126.68	48.52	75.56	16.30	9.26	3.33	4.82	18.52	3.33	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	63.96	24.42	11.63	6.98	5.81	1.16	1.16	5.81	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	87.79	35.96	34.91	13.75	5.29	1.06	2.12	6.35	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	125.25	42.42	53.62	18.41	11.60	3.20	5.20	26.41	4.40	6.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	86.50	39.98	29.80	13.81	5.81	0.73	7.27	11.63	4.36	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	114.21	36.03	31.43	20.70	6.90	3.83	3.07	16.10	4.60	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	131.71	30.09	58.21	15.78	10.36	1.97	3.95	17.26	3.45	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	105.38	31.05	36.70	16.00	7.53	0.94	2.82	8.47	1.88	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	111.12	36.20	31.68	17.60	5.03	2.01	3.52	11.06	4.53	4.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	132.48	36.05	42.36	21.18	5.41	3.15	6.31	16.67	3.60	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	92.94	27.54	41.31	10.33	6.88	0.00	3.44	13.77	3.44	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	144.29	39.19	44.09	19.15	3.56	2.67	5.34	12.47	4.45	6.68
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	144.68	39.10	44.97	18.77	11.34	2.74	4.30	14.86	3.52	6.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	95.66	37.60	34.31	16.49	9.24	3.30	3.96	9.24	5.94	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	114.68	38.92	36.32	17.64	8.82	0.52	4.67	14.01	4.15	5.19
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	144.40	42.44	59.07	22.75	11.38	2.19	8.31	15.75	5.69	6.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	111.82	34.66	40.81	18.45	4.47	5.03	2.80	11.74	5.59	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	120.13	34.45	29.59	15.02	7.95	1.77	6.18	7.07	5.30	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	148.89	43.20	46.29	22.37	8.49	1.54	5.40	14.66	3.86	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	122.03	36.46	35.44	19.24	5.57	1.52	2.53	11.14	3.04	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	128.33	38.45	29.80	17.78	10.09	3.84	5.29	8.65	4.81	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	141.13	39.36	49.69	19.08	9.94	1.59	5.57	21.47	4.77	4.37
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	144.61	40.10	48.00	19.44	7.90	1.22	1.82	7.90	3.04	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	105.14	38.04	48.42	15.22	4.84	1.38	5.53	13.14	2.77	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	155.42	39.14	43.32	21.28	9.50	3.42	3.80	18.62	3.80	4.94
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	134.78	38.73	43.90	18.59	10.33	1.55	3.10	11.88	4.65	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	122.14	37.49	30.23	16.93	4.23	1.21	1.81	9.07	3.02	4.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	139.12	41.83	58.63	19.96	3.80	2.85	4.12	28.84	4.44	5.70
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	102.89	36.78	39.98	11.73	4.80	1.60	1.60	9.60	4.80	4.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	123.55	29.31	38.50	12.64	2.30	0.57	5.17	8.62	4.60	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	134.22	45.25	63.77	24.17	4.63	1.03	2.57	17.48	4.63	5.14
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	103.27	32.54	49.51	22.64	6.37	0.00	3.54	9.20	5.66	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	121.44	41.99	32.35	13.05	4.54	0.57	1.13	17.59	4.54	6.81
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	110.25	38.27	48.26	16.64	9.98	0.42	4.16	22.47	5.41	5.82
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	92.40	36.02	56.38	18.79	4.70	0.00	4.70	8.61	7.05	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	101.05	39.25	50.11	10.44	5.01	0.42	2.92	15.87	3.34	4.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	113.84	39.96	55.76	18.59	3.25	1.86	3.72	13.01	4.18	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	89.65	50.18	38.80	12.04	4.68	1.34	2.01	6.69	6.69	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	105.86	41.70	39.03	10.69	6.42	1.60	4.28	14.44	3.74	4.81
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	106.28	37.58	48.09	14.14	5.25	2.02	3.23	7.68	2.83	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	80.76	39.46	43.13	14.68	3.67	1.84	0.92	9.18	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	109.36	51.57	61.35	12.45	9.78	0.00	3.56	23.12	3.56	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	112.26	59.27	76.93	21.66	11.97	1.71	6.84	10.26	3.42	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	104.30	42.18	42.95	12.27	5.37	0.00	2.30	9.97	3.07	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	131.32	60.74	67.30	15.87	6.57	2.19	5.47	15.32	2.74	7.11
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	110.47	47.22	57.02	19.15	7.13	1.34	3.56	8.46	3.12	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	138.56	37.17	30.93	20.28	6.50	0.78	3.90	5.20	4.68	4.42
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	98.14	50.40	39.79	15.25	3.98	1.33	3.98	17.90	3.98	5.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	120.56	83.14	122.64	37.41	8.31	2.08	6.24	18.71	6.24	4.16
Macrophage - monocyte derived, donor1	11232-116C8	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	0.00	0.00	3.72	0.00	0.00	0.00	0.00	2.12	0.00
Mallassez-derived cells, donor2	11929-125I3	6.02	0.32	0.48	8.24	0.95	1.27	0.00	0.48	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	15.71	3.20	2.36	9.31	0.69	2.92	0.28	0.28	1.11	0.00
Mammary Epithelial Cell, donor1	11273-116H4	7.27	3.39	0.50	7.07	1.20	0.50	0.30	0.50	0.50	0.60
Mammary Epithelial Cell, donor2	11350-117G9	9.56	4.05	1.45	5.79	0.58	0.00	0.58	0.00	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	9.73	1.75	1.75	5.49	0.25	4.24	0.25	0.00	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.00	0.00	0.00	0.11	0.00	0.00	0.00	0.00	0.11	0.00
Mast cell, donor2	11565-120D8	0.89	0.59	0.30	0.30	0.00	0.00	0.00	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	2.48	0.45	0.45	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	2.13	0.18	0.53	0.71	0.00	0.00	0.18	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	145.47	61.99	63.68	12.84	10.65	0.20	7.76	4.48	4.18	4.38
Melanocyte - dark, donor2	11582-120F7	21.11	6.58	5.88	10.73	2.42	0.35	0.35	0.35	2.77	0.00
Melanocyte - dark, donor3	11663-122F7	8.19	2.17	1.30	5.58	0.94	0.00	0.43	0.43	0.43	0.22
Melanocyte - light, donor1	11274-116H5	11.05	5.41	4.23	7.76	2.35	0.00	0.94	0.00	0.24	1.41
Melanocyte - light, donor2	11351-117H1	10.92	8.19	2.73	7.51	2.05	0.00	0.68	0.00	0.68	1.36
Melanocyte - light, donor3	11423-118G1	10.41	2.60	5.20	1.73	1.73	0.00	0.00	2.60	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.45	6.87	6.66	9.58	1.25	0.42	0.42	0.52	1.87	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	5.65	2.42	1.08	4.57	0.81	0.27	0.27	0.27	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	27.86	9.37	7.77	15.00	1.34	0.00	1.87	0.80	1.34	1.07
Meningeal Cells, donor1	11493-119E8	266.48	79.15	71.71	33.99	8.19	12.16	7.69	11.79	13.65	4.22
Meningeal Cells, donor2	11573-120E7	169.90	51.94	80.55	11.44	11.88	9.68	11.44	13.20	9.68	5.28
Meningeal Cells, donor3	11654-122E7	188.92	46.13	60.88	26.00	6.93	12.39	7.91	4.89	12.31	3.26
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	57.60	27.95	21.39	11.41	3.99	3.14	4.85	1.43	3.99	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.84	12.98	4.23	11.07	5.43	9.16	1.61	1.31	1.81	2.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	34.17	39.42	24.97	6.57	1.31	0.00	6.57	1.31	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	30.09	17.01	10.47	5.23	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.96	7.89	7.89	5.74	2.15	0.00	0.72	2.15	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	109.91	58.87	20.75	15.46	24.14	71.37	25.62	8.68	5.51	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	97.51	60.32	56.80	16.08	11.56	58.81	15.58	13.57	4.52	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	71.42	27.91	15.82	16.92	4.18	2.20	0.88	1.98	4.61	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	46.76	16.80	16.07	9.50	1.46	1.46	0.73	0.73	5.11	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	99.23	32.12	32.53	15.96	3.89	4.71	3.89	4.09	5.12	2.66
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	36.98	31.86	17.31	5.82	4.43	1.66	4.43	5.82	0.28	2.91
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	59.85	24.91	22.68	13.01	5.58	0.00	4.09	1.12	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	78.68	46.71	52.37	11.05	5.79	1.32	9.08	4.47	2.50	3.42
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	38.28	16.02	3.56	14.24	5.34	0.59	2.97	1.48	2.37	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	18.68	11.68	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.05	17.93	10.89	3.84	3.20	0.64	0.64	1.92	1.92	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.91	9.57	5.32	3.19	1.06	1.06	1.06	0.35	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	54.41	31.90	30.33	4.38	4.07	0.94	4.69	2.81	0.31	3.13
Mesenchymal stem cells - umbilical, donor0	11214-116A8	25.40	7.26	4.35	5.81	0.73	0.73	0.73	1.45	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	24.40	5.57	3.71	7.96	2.92	4.77	1.06	0.80	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	15.51	2.00	1.50	6.01	2.00	3.50	1.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	24.28	5.85	5.20	5.93	4.48	3.61	0.65	1.30	0.43	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	0.00	0.00	0.00	6.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	67.22	24.34	14.43	12.06	11.42	12.93	9.05	4.52	2.15	2.59
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	151.56	49.65	64.80	21.43	12.54	15.16	15.16	9.93	1.05	5.75
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	172.21	124.82	97.45	20.02	4.00	4.67	9.34	5.34	7.34	4.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	73.87	70.54	32.55	16.69	6.26	2.92	2.50	1.67	1.25	4.17
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	245.66	115.80	149.83	32.32	1.71	9.13	4.94	4.18	9.70	6.27
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	416.52	175.54	285.66	71.81	19.15	3.19	4.79	14.36	6.38	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	90.43	104.03	107.43	9.52	7.48	2.04	8.16	1.36	3.40	14.96
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	69.83	18.38	38.59	7.35	3.68	7.35	3.68	12.86	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	61.52	71.57	62.78	8.37	1.67	2.93	5.02	1.67	1.26	7.53
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	79.96	72.06	44.16	11.62	1.86	4.18	3.02	2.09	1.86	8.83
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	110.25	113.50	108.36	11.35	3.24	3.78	11.89	2.43	3.78	11.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	87.67	62.44	55.29	18.71	6.31	2.31	7.57	2.73	2.52	5.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	66.81	77.94	11.13	0.00	22.27	11.13	22.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	48.64	43.18	48.64	8.44	2.48	2.48	7.94	2.48	1.49	7.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	80.93	44.39	45.20	8.93	2.17	3.79	0.81	3.25	0.81	4.33
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	53.04	58.03	63.47	7.71	1.81	4.08	4.08	2.49	0.68	5.21
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	96.51	68.42	77.24	13.06	2.29	3.27	4.25	2.29	1.31	8.17
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	56.86	38.64	59.42	15.49	2.92	0.55	4.92	4.01	3.65	4.01
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	55.70	66.30	81.16	7.96	3.18	4.24	8.49	3.71	1.59	5.83
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	46.22	39.62	55.83	5.40	1.80	2.40	3.60	0.60	0.60	6.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	143.41	38.72	62.03	23.30	0.98	5.91	1.64	3.94	3.61	4.92
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	48.79	47.32	46.67	9.11	1.63	1.95	2.11	2.28	0.98	5.37
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	87.84	38.98	55.03	21.69	4.59	0.71	5.12	1.59	3.00	5.29
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	37.97	54.15	43.60	11.25	0.70	2.11	2.81	1.41	1.41	4.92
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.51	51.03	68.50	10.57	1.84	0.46	1.38	2.76	0.92	4.60
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	58.16	42.10	43.70	9.32	0.96	1.61	1.93	1.61	1.61	6.75
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	111.40	33.80	75.19	14.49	1.38	6.90	2.76	6.90	0.34	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	182.05	40.46	88.50	42.98	12.64	7.59	7.59	17.70	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	75.30	29.41	34.09	18.49	1.34	0.45	1.78	1.78	2.23	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	55.46	46.15	62.24	8.47	1.27	2.96	2.96	4.23	1.27	5.93
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	66.70	42.96	51.98	13.05	0.47	1.90	1.66	2.61	0.95	4.98
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	49.79	37.77	28.76	6.87	1.29	2.15	1.29	0.86	0.43	4.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	18.06	72.22	9.03	18.06	18.06	0.00	9.03	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	64.31	47.98	47.65	8.00	2.00	3.67	6.33	0.67	2.33	5.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	65.83	14.43	22.99	28.86	2.25	0.90	0.45	1.35	2.71	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.04	25.79	36.90	4.36	0.79	2.78	1.98	1.19	0.40	3.17
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	41.79	20.43	44.57	9.29	0.93	0.00	0.93	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	55.62	39.35	49.57	10.97	2.27	5.68	0.76	1.14	1.14	4.16
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	47.91	21.51	21.18	7.50	0.65	1.96	2.61	1.63	1.63	3.58
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	118.10	62.32	75.39	14.82	4.36	0.87	4.36	1.31	2.18	4.79
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	64.22	19.00	23.52	23.52	2.71	1.81	2.26	1.36	1.36	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	49.39	29.98	36.16	11.46	1.76	6.17	2.65	2.65	2.65	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	26.59	35.24	40.56	7.31	0.66	0.66	0.00	1.33	1.33	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	56.05	36.71	29.27	8.93	1.98	2.48	4.46	1.49	1.98	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	43.64	40.96	22.97	8.80	1.91	3.83	1.15	1.53	1.53	3.06
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	81.96	43.55	62.61	13.01	1.51	4.23	2.42	4.84	0.91	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	30.94	11.05	11.94	16.13	1.77	0.44	1.33	1.11	2.21	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.30	29.14	42.01	7.45	0.68	0.68	4.07	1.36	1.36	4.74
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	10.22	45.99	20.44	0.00	5.11	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	50.60	42.07	31.70	11.58	0.61	1.22	1.83	1.22	2.44	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	40.29	21.09	17.63	8.18	0.94	1.57	1.26	0.63	0.31	3.15
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	109.86	104.42	111.38	11.50	2.42	2.12	4.54	1.82	2.12	6.66
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	21.36	14.24	18.99	11.08	0.79	1.58	0.79	0.79	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	130.37	41.94	79.36	21.54	0.00	3.40	1.13	3.40	1.13	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	15.17	35.41	10.12	0.00	0.00	0.00	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	11.30	2.86	1.12	5.84	1.12	0.25	0.50	0.50	0.99	0.50
Myoblast, donor2	11322-117D8	43.15	17.84	18.03	7.48	3.26	0.77	3.84	3.45	1.53	1.53
Myoblast, donor3	11398-118D3	12.44	3.87	1.18	8.74	0.84	0.50	0.67	0.50	1.51	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.15	0.00	0.00	0.00	0.29	0.00	0.15	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.60	0.00	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	7.98	2.54	0.36	13.79	0.36	0.00	1.09	0.36	0.00	1.09
Neural stem cells, donor2	11352-117H2	25.03	5.78	9.63	3.85	3.85	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	21.62	7.97	4.55	5.69	0.00	1.14	1.14	1.14	1.14	5.69
Neurons, donor2	11574-120E8	17.17	5.50	4.62	4.84	0.66	0.22	0.66	0.22	1.10	1.10
Neurons, donor3	11655-122E8	21.38	9.87	18.09	7.40	0.00	0.00	0.82	2.47	2.47	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	34.79	10.33	9.14	17.10	2.85	2.49	2.14	1.66	1.31	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	41.03	31.58	34.84	10.42	9.12	2.28	4.88	1.63	4.56	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	34.09	19.85	13.44	5.01	3.01	1.80	0.80	3.21	0.80	1.60
Olfactory epithelial cells, donor1	11933-125I7	101.45	48.04	63.04	16.24	5.64	22.16	7.98	9.50	2.34	4.27
Olfactory epithelial cells, donor2	11934-125I8	67.02	22.73	41.11	15.34	2.75	12.16	2.46	4.78	1.59	1.88
Olfactory epithelial cells, donor3	11935-125I9	73.55	41.54	57.09	10.56	4.65	18.16	6.13	7.83	1.93	3.41
Olfactory epithelial cells, donor4	11936-126A1	142.30	53.47	74.90	23.57	4.19	20.75	4.87	6.33	4.58	3.51
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	11.43	13.84	7.22	1.81	0.60	1.20	0.60	1.81	1.81
Osteoblast - differentiated, donor1	11276-116H7	27.44	8.72	4.47	8.08	2.55	2.34	2.98	0.21	0.21	1.49
Osteoblast - differentiated, donor2	11353-117H3	9.14	2.29	3.43	2.29	1.14	0.00	1.14	1.14	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	19.24	10.55	3.72	6.83	0.62	0.62	2.48	5.59	2.48	1.24
Osteoblast, donor1	11277-116H8	87.56	42.21	13.09	10.94	8.21	12.31	14.07	1.95	3.32	4.69
Osteoblast, donor2	11354-117H4	125.71	39.33	17.56	26.69	11.94	21.07	7.73	3.51	14.75	3.51
Osteoblast, donor3	11426-118G4	57.76	15.82	11.02	10.31	6.40	11.37	5.87	1.07	3.55	2.84
Pancreatic stromal cells, donor1	11249-116E7	83.39	50.54	29.99	14.83	6.91	11.37	9.69	4.80	2.86	5.81
Pericytes, donor1	11491-119E6	145.76	97.69	80.00	16.13	16.36	2.78	25.59	16.24	3.56	5.12
Pericytes, donor2	11571-120E5	140.80	67.00	71.31	15.85	11.32	5.43	14.94	16.52	2.94	6.11
Pericytes, donor3	11652-122E5	77.92	22.18	31.74	8.54	6.51	3.46	7.12	7.93	2.24	4.27
Perineurial Cells, donor1	11499-119F5	76.63	47.81	33.23	10.06	5.43	4.97	5.88	3.28	1.58	2.37
Perineurial Cells, donor2	11579-120F4	33.86	6.62	6.16	15.55	2.21	0.18	0.74	0.92	3.68	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	9.33	2.15	1.67	6.46	0.48	1.91	0.72	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	28.83	4.44	5.54	12.20	3.33	12.20	0.00	0.00	6.65	1.11
Placental Epithelial Cells, donor3	11427-118G5	31.61	7.07	5.30	9.03	2.75	11.98	0.98	1.18	2.16	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	40.19	20.57	21.52	6.96	2.85	4.43	3.48	3.16	1.27	0.95
Preadipocyte - breast, donor1	11467-119B9	66.03	38.46	24.76	10.69	12.57	7.32	11.44	4.88	2.06	3.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	50.25	20.62	8.88	13.71	5.48	7.31	4.57	1.96	1.17	2.09
Preadipocyte - breast, donor2	11328-117E5	46.83	19.81	20.94	8.11	5.63	3.60	6.08	2.48	1.13	0.68
Preadipocyte - omental, donor1	11468-119C1	114.12	50.51	47.31	10.55	17.16	15.13	22.59	6.71	2.98	5.01
Preadipocyte - omental, donor2	11329-117E6	41.03	17.90	11.78	13.97	3.49	3.49	4.80	0.44	3.06	2.62
Preadipocyte - omental, donor3	11403-118D8	60.16	32.95	19.34	12.46	11.17	10.46	12.32	4.01	2.15	3.01
Preadipocyte - perirenal, donor1	11469-119C2	31.50	8.86	13.78	4.92	2.95	5.91	3.94	4.92	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	60.50	23.65	6.14	8.60	6.76	11.06	4.61	0.92	5.53	2.76
Preadipocyte - subcutaneous, donor2	11356-117H6	111.20	70.30	64.99	23.73	10.27	12.93	11.69	9.39	10.80	5.49
Preadipocyte - subcutaneous, donor3	11428-118G6	95.36	40.02	37.63	13.11	12.09	14.64	12.09	4.60	3.92	3.58
Preadipocyte - visceral, donor1	11280-116I2	100.97	43.87	21.24	19.19	11.27	8.10	10.71	4.10	6.99	4.38
Preadipocyte - visceral, donor2	11357-117H7	84.67	37.27	43.26	19.79	13.81	10.58	7.82	5.52	7.36	3.22
Preadipocyte - visceral, donor3	11429-118G7	78.26	38.66	37.83	11.70	8.99	6.16	9.72	9.82	6.37	3.34
Prostate Epithelial Cells (polarized), donor1	11253-116F2	39.98	9.96	7.24	9.20	2.26	3.32	3.77	2.26	2.41	3.17
Prostate Epithelial Cells, donor2	11331-117E8	17.87	6.50	3.52	8.12	4.06	5.42	2.71	1.08	1.35	0.95
Prostate Epithelial Cells, donor3	11404-118D9	12.31	2.27	1.29	7.35	0.86	0.37	0.67	0.43	0.80	0.61
Prostate Stromal Cells, donor1	11254-116F3	35.08	20.73	11.28	6.61	2.51	5.01	2.96	3.08	2.39	2.16
Prostate Stromal Cells, donor2	11332-117E9	79.25	56.12	55.22	9.50	9.14	8.25	8.43	8.07	2.87	5.02
Prostate Stromal Cells, donor3	11405-118E1	36.60	29.72	18.25	5.53	4.28	6.57	5.53	3.65	0.52	2.71
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.21	13.14	6.57	9.85	3.28	1.82	2.19	2.55	1.82	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.90	10.40	6.24	10.26	2.70	1.59	1.18	1.04	1.32	0.97
Renal Epithelial Cells, donor1	11517-119H5	36.52	24.85	7.61	9.13	1.01	2.03	1.01	1.01	5.07	2.03
Renal Epithelial Cells, donor2	11597-120H4	45.52	19.92	10.67	12.80	1.42	1.42	3.56	0.00	3.56	0.71
Renal Epithelial Cells, donor3	11678-122H4	31.12	15.99	6.88	12.49	2.65	1.38	0.85	1.16	1.91	1.59
Renal Glomerular Endothelial Cells, donor1	11514-119H2	104.17	38.13	44.26	12.94	5.45	0.00	2.72	3.40	0.68	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	107.68	35.31	42.72	10.65	4.72	1.21	2.83	8.36	4.45	2.29
Renal Glomerular Endothelial Cells, donor3	11675-122H1	82.14	33.30	34.86	19.98	5.77	2.66	3.11	6.88	5.11	3.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	94.49	32.61	38.60	17.30	2.66	0.67	1.33	2.66	3.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	105.86	69.33	28.61	15.85	14.53	10.12	16.07	5.06	10.78	3.96
Renal Mesangial Cells, donor2	11598-120H5	55.80	43.89	25.08	11.29	10.66	5.02	15.67	5.64	2.51	3.13
Renal Mesangial Cells, donor3	11679-122H5	54.65	42.72	19.42	8.04	8.88	5.55	11.10	1.94	1.11	3.33
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	46.44	16.11	10.20	14.49	4.03	5.64	1.88	1.07	4.29	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.94	11.39	11.39	10.54	2.53	3.80	1.69	0.84	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.68	15.81	5.40	11.57	1.93	2.31	0.96	0.96	3.09	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.19	14.78	12.96	5.19	1.56	1.30	0.00	1.81	1.56	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	59.69	30.98	15.63	17.34	5.40	4.55	1.99	2.27	2.27	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	27.79	16.47	9.26	6.17	0.00	0.00	1.03	2.06	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	43.91	17.06	10.29	6.27	4.27	4.01	3.26	2.76	1.25	2.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	125.22	31.94	55.46	18.17	2.94	3.74	7.62	5.08	3.07	2.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.04	0.00	0.00	4.47	0.00	0.00	0.89	0.89	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	2.20	1.10	15.96	0.55	0.00	0.00	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	1.16	0.58	13.92	0.00	0.00	0.58	0.00	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.22	4.68	0.26	11.83	0.26	0.39	0.00	1.43	0.78	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.21	2.68	0.89	6.75	0.30	0.00	0.20	0.20	1.29	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.82	2.68	0.22	8.70	0.45	0.00	0.22	0.45	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.43	2.36	0.25	7.81	0.62	0.12	0.25	1.74	1.49	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.12	1.98	0.93	7.46	0.35	0.00	0.23	0.47	0.82	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.48	3.47	1.85	12.25	1.16	0.00	0.23	0.92	0.92	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.41	2.05	0.55	6.98	0.14	0.00	0.68	1.37	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	14.07	3.18	1.06	7.56	0.45	0.00	0.30	0.61	0.30	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.39	2.51	0.18	7.53	0.54	0.00	0.00	0.54	0.90	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.89	2.15	0.86	7.75	0.29	0.00	0.43	1.58	0.57	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	9.98	2.90	1.50	7.83	0.11	0.00	0.21	0.54	0.86	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.96	3.32	0.66	8.41	0.22	0.00	0.22	1.77	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.09	2.29	0.57	8.22	0.38	0.19	0.38	1.72	1.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	11.18	3.35	0.84	5.68	0.37	0.00	0.19	0.75	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	15.22	2.44	0.75	14.66	0.75	0.19	0.38	1.32	1.32	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.28	1.86	0.27	8.63	0.66	0.00	0.00	1.59	0.80	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	11.10	2.43	0.49	7.30	0.39	0.00	0.19	0.49	1.07	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	11.65	1.72	1.15	8.59	0.38	0.00	0.00	1.15	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.57	2.46	0.96	6.73	0.53	0.00	0.64	0.96	0.53	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.21	1.96	0.56	13.73	0.56	0.00	0.00	0.84	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.60	2.56	1.03	9.91	0.00	0.00	0.51	0.85	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.84	1.09	0.18	7.84	0.91	0.18	0.18	1.09	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	9.57	2.21	0.49	7.85	0.98	0.00	0.25	0.74	1.10	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.87	1.48	0.54	6.72	0.81	0.00	0.27	0.27	0.94	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.26	3.30	0.71	8.96	0.24	0.00	0.24	2.83	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.52	1.98	1.98	9.33	0.40	0.00	0.20	0.20	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	10.76	3.27	1.40	10.76	0.47	0.00	0.00	0.47	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	5.81	3.32	1.04	10.37	0.41	0.00	0.21	1.66	1.45	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.72	2.88	0.44	8.41	0.88	0.00	0.44	0.00	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	9.82	2.09	0.84	7.52	0.42	0.00	0.42	0.63	1.46	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.84	2.56	1.08	8.08	0.54	0.00	0.00	2.42	0.54	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.84	2.04	0.00	11.24	0.68	0.00	0.34	0.51	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.46	3.47	0.77	10.60	0.58	0.00	0.39	0.77	2.70	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.42	4.13	1.03	8.25	0.69	0.17	0.17	2.92	2.06	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.85	3.43	0.82	8.37	0.55	0.00	0.00	0.27	1.23	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	15.92	4.76	2.46	11.98	0.33	0.00	0.49	1.31	1.81	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.40	1.36	1.02	10.06	0.34	0.17	0.34	1.53	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	10.50	1.92	0.15	6.21	0.44	0.00	0.30	1.18	0.30	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.99	2.40	0.27	17.59	0.53	0.00	0.27	1.60	2.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	4.70	0.83	0.14	4.29	0.14	0.00	0.28	0.83	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	6.90	1.19	0.00	9.29	0.48	0.00	0.00	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	23.18	3.22	0.81	21.16	0.81	0.00	0.60	0.81	3.02	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.25	0.57	0.57	6.69	0.47	0.00	0.09	0.66	0.57	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	8.04	1.75	0.35	7.34	0.70	0.00	0.00	0.35	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	4.53	0.91	0.60	8.46	0.00	0.00	0.00	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.12	0.73	0.24	8.08	0.00	0.00	0.61	0.98	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	9.90	0.73	0.00	12.81	0.58	0.00	0.29	1.02	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	6.69	0.00	0.61	9.73	0.00	0.00	0.61	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4.52	0.60	0.60	8.14	0.00	0.00	0.60	0.60	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	4.75	0.00	0.23	6.79	0.00	0.00	0.90	0.00	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	4.49	1.20	0.30	8.09	0.00	0.00	0.00	0.30	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	5.55	0.71	0.24	8.50	0.12	0.00	0.94	1.53	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	4.27	0.43	0.21	5.55	0.00	0.00	0.85	0.00	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	0.00	1.20	6.01	0.00	0.00	0.00	0.00	1.20	1.20
Schwann Cells, donor1	11498-119F4	67.33	34.23	28.77	10.53	3.57	2.44	3.20	5.83	2.44	2.26
Schwann Cells, donor2	11578-120F3	68.05	61.24	51.04	10.21	13.61	0.00	6.80	3.40	6.80	3.40
Schwann Cells, donor3	11659-122F3	67.04	43.16	49.07	14.02	9.86	10.52	8.98	5.92	4.82	4.16
Sebocyte, donor1	11220-116B5	19.72	2.74	2.74	12.60	2.19	0.00	0.55	0.55	2.19	0.00
Sebocyte, donor2	11301-117B5	7.35	0.92	0.46	3.68	0.92	1.38	0.92	0.92	0.46	0.46
Sebocyte, donor3	11378-118B1	20.82	3.50	6.60	5.98	1.24	0.82	1.03	0.82	1.86	0.62
Sertoli Cells, donor1	11255-116F4	82.83	26.51	26.51	6.63	3.31	16.57	9.94	6.63	0.00	1.66
Sertoli Cells, donor2	11333-117F1	81.91	42.37	79.08	5.65	0.00	16.95	19.77	11.30	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	66.34	26.92	11.09	19.09	4.84	3.87	5.63	1.85	1.14	3.52
Skeletal Muscle Cells, donor2	11358-117H8	17.35	5.78	10.12	3.61	0.00	0.00	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	56.01	26.75	31.77	8.36	0.00	2.51	3.34	2.51	1.67	4.18
Skeletal Muscle Cells, donor4	11451-119A2	38.33	25.14	24.51	9.27	1.57	3.14	3.77	3.30	2.04	2.20
Skeletal Muscle Cells, donor5	11455-119A6	32.85	19.47	22.89	6.39	1.78	1.04	1.34	2.82	1.49	1.49
Skeletal Muscle Cells, donor6	11459-119B1	43.71	19.39	16.62	7.23	2.15	2.31	2.15	2.92	2.62	2.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.63	26.97	20.03	11.59	2.65	1.64	3.40	3.78	2.14	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.39	18.83	22.26	8.70	2.71	1.28	3.57	2.28	1.28	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	60.12	25.89	26.39	9.33	2.18	3.27	3.27	1.98	3.37	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	56.87	17.10	8.09	19.88	3.37	5.98	4.30	2.02	2.70	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.92	8.69	10.13	4.34	3.62	0.72	0.72	2.17	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	44.86	30.55	28.35	3.85	8.26	6.47	9.08	4.27	0.96	2.89
Skin - palm, donor1	10286-104F7	115.50	16.12	29.55	10.74	0.00	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.00	3.32	3.03	6.78	0.29	1.44	0.43	0.14	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	24.54	4.91	9.00	20.45	0.82	4.09	0.00	1.64	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.97	2.99	3.12	4.54	1.04	0.65	0.39	0.91	1.17	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	9.04	3.34	1.25	6.53	0.42	0.97	0.70	0.28	0.56	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	13.08	1.97	2.67	4.64	1.83	0.56	0.28	0.42	0.84	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.60	4.86	5.29	12.48	1.48	1.48	0.42	1.06	3.17	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	11.32	2.70	1.35	5.92	1.20	0.22	0.37	0.30	0.97	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	21.29	13.89	8.95	7.10	4.94	3.39	3.09	8.02	1.23	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	32.02	10.89	8.45	8.23	7.11	5.78	4.00	4.22	1.78	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	33.51	11.76	4.11	9.41	3.53	4.11	2.35	1.18	4.11	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	38.01	10.83	7.07	16.57	1.77	1.55	1.10	7.51	2.21	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	33.08	6.30	3.54	6.30	3.15	5.12	1.18	0.39	2.36	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	47.13	14.68	4.64	10.82	3.86	4.64	1.55	0.00	6.18	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	38.03	30.02	10.01	0.00	1.00	2.00	2.00	1.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.42	6.52	2.53	6.65	3.73	1.20	2.13	0.67	1.46	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	83.34	23.94	27.26	9.75	9.31	6.87	7.09	8.64	3.55	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.12	1.66	1.02	2.56	0.90	0.90	0.77	0.00	0.00	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	49.16	15.95	21.16	4.88	4.56	8.14	3.91	1.95	1.63	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	101.30	39.57	32.19	7.68	8.86	13.29	12.70	5.32	4.13	5.02
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	32.46	11.39	8.97	4.13	4.84	4.56	1.42	1.14	0.28	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.33	33.19	19.68	7.97	5.37	4.23	5.04	2.77	3.74	2.93
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	70.32	69.11	59.36	12.79	6.39	1.83	5.18	9.44	3.35	4.26
Smooth Muscle Cells - Carotid, donor1	11285-116I7	94.71	34.35	16.16	13.13	8.84	5.56	6.06	2.02	3.54	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	12.24	12.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	1.91	1.91	3.34	0.48	0.48	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.26	20.20	13.86	6.34	2.36	6.05	2.06	2.51	1.62	1.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	38.96	24.97	21.95	5.17	3.44	2.37	5.17	2.37	0.65	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.57	24.67	21.10	5.25	3.15	2.10	3.46	1.36	1.36	1.89
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.65	12.37	4.64	9.13	5.26	3.56	2.01	1.24	2.94	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	3.23	1.08	4.31	2.16	0.00	1.08	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.44	5.08	4.18	5.08	0.60	2.39	1.20	0.60	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	60.77	32.77	16.73	14.00	1.37	2.39	4.10	2.73	2.05	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	67.77	36.52	43.58	8.56	5.26	1.73	5.65	3.22	1.18	3.61
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	65.52	14.59	7.15	22.04	6.04	7.35	8.96	2.82	5.33	3.52
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	43.01	9.78	14.56	15.93	3.19	3.19	2.05	3.19	1.37	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	5.43	2.42	6.64	3.02	3.02	3.02	3.02	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	59.61	28.61	18.81	12.45	1.85	1.85	1.32	2.91	4.24	2.38
Smooth Muscle Cells - Prostate, donor1	11257-116F6	71.77	91.88	36.49	6.66	9.59	14.78	18.64	15.31	3.46	5.86
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.92	16.78	12.02	7.39	2.63	0.88	2.75	2.13	0.38	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	93.35	57.84	34.75	6.34	16.23	6.09	21.56	6.60	2.79	4.57
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	75.09	32.72	16.43	14.17	9.95	7.69	7.09	1.36	3.02	2.11
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	9.00	12.75	3.00	2.25	0.75	1.50	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	175.74	42.64	56.86	83.99	5.17	0.00	5.17	76.24	10.34	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	56.74	22.79	8.37	8.37	6.98	4.19	5.12	2.79	6.05	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.11	1.01	0.50	3.53	1.51	2.02	1.01	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.54	5.95	4.70	4.70	2.19	1.25	1.57	0.31	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.27	20.06	20.06	7.96	6.19	2.95	5.60	1.47	1.47	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	74.64	45.15	26.91	10.66	6.58	5.91	7.25	2.33	4.58	3.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	61.67	52.32	64.94	8.41	8.88	4.20	12.61	5.14	0.93	5.61
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.40	5.76	1.44	6.48	2.16	2.16	0.58	0.00	0.86	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.83	5.86	3.57	5.35	1.78	1.78	1.27	0.51	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	25.20	14.48	11.47	4.89	1.32	2.44	3.20	1.88	1.50	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.29	39.83	24.04	9.36	4.33	4.75	3.35	2.66	3.49	3.07
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.26	13.32	5.95	5.28	1.68	2.26	0.84	0.75	0.50	1.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	20.95	19.05	10.95	1.90	1.90	0.48	2.38	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.01	2.69	0.24	5.14	0.73	2.94	0.98	0.24	0.49	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	92.14	86.39	42.20	12.59	17.01	27.62	15.47	14.36	3.98	4.42
Smooth Muscle Cells - Uterine, donor3	11466-119B8	88.07	33.94	55.30	6.73	2.05	2.05	4.97	2.34	2.93	2.93
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	76.97	27.60	32.85	14.19	1.94	3.11	1.94	2.72	2.92	2.33
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	80.66	39.14	51.04	12.16	16.13	11.37	11.90	8.46	3.44	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	37.19	29.76	30.87	10.41	1.49	4.09	4.46	2.23	1.12	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	35.93	25.87	16.89	5.75	5.39	3.23	5.39	1.80	0.36	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	36.06	18.74	11.64	11.64	5.96	2.27	3.97	1.42	0.85	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	74.05	41.75	38.21	15.75	0.79	10.63	9.85	4.73	5.91	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	56.12	30.73	30.47	10.16	2.79	1.78	3.56	3.05	1.27	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	67.88	22.36	23.96	17.17	1.60	0.40	2.00	2.80	2.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	52.67	25.92	32.60	7.11	3.76	2.93	5.43	2.09	0.42	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	51.34	31.63	47.21	9.63	1.83	2.29	1.83	3.21	1.83	0.46
Synoviocyte, donor1	11291-117A4	44.94	8.92	8.25	14.48	1.85	4.88	1.85	2.02	2.02	0.84
Synoviocyte, donor2	11368-117I9	3.52	0.34	0.34	3.18	0.00	0.00	0.17	0.34	0.17	0.00
Synoviocyte, donor3	11440-118H9	15.42	4.47	4.92	4.47	0.45	0.45	0.89	2.23	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	37.88	13.22	7.15	22.15	2.50	0.36	1.07	1.43	3.57	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	5.95	0.00	3.96	0.00	0.00	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	20.84	5.79	3.24	5.33	0.93	0.23	0.23	0.46	0.69	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	13.69	3.37	2.51	5.38	0.86	0.65	0.14	0.57	0.86	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	3.48	3.48	4.64	1.16	0.77	0.00	0.39	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	1.72	0.00	4.01	0.57	1.15	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	121.42	30.51	57.94	18.21	2.71	3.44	5.17	6.64	2.58	2.83
Urethra, donor2	10319-105A4	131.29	64.74	109.70	17.98	5.40	3.60	0.00	12.59	3.60	5.40
Urothelial Cells, donor1	11520-119H8	19.13	7.44	6.38	9.30	1.06	1.86	0.53	0.27	0.27	0.53
Urothelial Cells, donor2	11600-120H7	12.82	5.21	4.01	3.61	0.80	0.80	0.80	0.40	0.40	1.20
Urothelial Cells, donor3	11681-122H7	15.13	4.13	5.73	5.04	0.46	0.46	0.92	0.69	0.00	0.92
Urothelial cells, donor0	11216-116B1	14.04	6.91	2.45	5.35	1.56	0.67	0.22	0.45	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	11.23	15.91	1.85	4.07	3.70	0.99	3.08	1.73	0.37	1.73
Wilms' tumor cell line:HFWT	10597-108E3	31.68	5.28	6.16	7.04	0.00	2.64	0.88	0.88	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	20.95	20.11	8.66	9.50	1.96	7.82	1.12	0.56	5.31	1.96
achilles tendon, donor2	10292-104G4	144.66	43.40	78.53	12.40	2.07	0.00	2.07	10.33	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.27	0.54	0.00	1.63	0.00	0.00	0.00	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.21	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	3.54	0.00	0.00	6.53	0.27	0.00	0.00	0.00	2.18	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	0.44	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.00	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	24.84	6.81	2.94	13.62	0.92	0.00	0.18	2.02	2.58	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.70	0.52	0.00	5.18	0.00	0.00	0.00	0.00	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.92	0.29	0.29	2.92	0.29	0.00	0.00	0.00	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1.86	0.00	0.00	0.46	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.68	1.53	0.31	2.76	0.00	0.00	0.00	0.00	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.85	0.43	0.00	3.84	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.82	0.00	0.00	2.12	0.00	0.00	0.30	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.61	1.20	0.00	3.13	0.00	0.00	0.24	0.00	0.00	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.72	6.24	6.68	9.36	0.45	0.45	0.22	0.67	1.78	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	50.47	13.56	9.42	25.99	2.26	0.75	0.75	2.64	6.78	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	0.00	0.00	1.87	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	26.61	18.13	3.77	17.90	1.65	0.00	0.00	0.24	0.24	1.18
adipose tissue, adult, pool1	10010-101C1	102.22	36.92	51.19	13.50	2.64	1.40	4.65	2.79	2.64	3.88
adipose, donor1	10184-103D4	215.80	186.48	79.17	70.96	18.77	18.18	39.29	43.98	9.97	65.09
adipose, donor2	10185-103D5	233.58	151.26	89.21	55.56	6.08	1.22	18.25	18.65	8.92	42.17
adipose, donor3	10186-103D6	159.29	77.87	43.29	37.85	12.53	4.90	10.89	6.81	6.53	23.14
adipose, donor4	10187-103D7	145.61	45.94	35.54	40.74	8.67	4.33	9.53	163.82	6.07	13.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.04	13.89	3.79	11.99	4.89	0.00	1.74	0.79	1.42	3.79
adrenal gland, adult, pool1	10081-102A9	61.84	18.19	47.29	0.00	3.64	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	65.74	159.00	28.23	6.79	31.09	31.09	50.74	15.72	1.79	20.01
amniotic membrane cells, donor1	12235-129G3	23.42	2.09	1.62	15.07	0.93	2.78	0.23	1.39	1.85	0.23
amniotic membrane cells, donor2	12236-129G4	29.41	7.10	2.70	17.92	2.03	9.13	1.35	14.88	2.03	0.68
amniotic membrane cells, donor3	12237-129G5	19.44	2.95	2.06	12.37	0.59	5.89	0.00	3.24	2.06	0.59
amygdala - adult, donor10196	10167-103B5	59.29	20.16	28.46	17.79	4.74	3.56	5.93	2.37	4.74	1.19
amygdala, adult, donor10252	10151-102I7	115.58	20.48	56.17	29.20	4.26	2.84	5.88	12.17	3.24	2.64
amygdala, newborn, donor10223	10360-105E9	123.30	36.15	84.57	28.73	2.58	5.16	4.84	11.94	2.58	4.20
anaplastic carcinoma cell line:8305C	10428-106D5	77.67	35.02	23.43	12.99	8.28	3.95	3.95	4.07	1.02	4.58
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	69.81	23.05	11.02	34.07	2.34	0.00	1.00	5.01	5.68	1.00
aorta, adult, pool1	10052-101G7	96.50	21.97	49.03	20.20	2.16	4.51	1.57	3.14	1.96	0.59
appendix, adult	10189-103D9	72.19	26.39	46.57	8.54	2.72	4.27	1.55	3.49	2.33	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	10.66	9.29	0.69	12.38	0.69	0.00	0.34	0.69	0.00	0.69
artery, adult	10190-103E1	61.14	14.95	46.20	2.72	1.36	1.36	0.00	5.43	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	0.00	0.00	0.00	0.00	0.00	6.37	0.00	0.14	0.00	0.00
b cell line:RPMI1788	10427-106D4	23.49	3.27	0.59	9.96	1.64	0.00	0.74	1.34	0.30	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	21.64	7.21	3.33	6.10	0.28	0.28	1.11	1.11	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	79.88	50.51	18.85	12.01	9.53	13.00	10.82	3.47	2.78	4.17
bile duct carcinoma cell line:TFK-1	10496-107C1	50.72	24.44	7.87	20.92	3.68	0.67	1.17	2.51	1.00	3.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	121.46	49.32	62.90	17.93	3.15	6.84	5.00	2.50	1.74	2.93
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	21.41	7.71	19.70	5.99	0.00	2.57	2.57	0.00	2.57
bone marrow, adult	10192-103E3	31.04	9.45	21.59	6.07	4.05	0.67	0.00	4.05	1.35	0.00
brain, adult, donor1	10084-102B3	24.60	4.10	19.48	2.05	1.03	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	20.16	3.23	7.13	3.45	0.45	0.67	0.56	0.56	0.33	0.78
brain, fetal, pool1	10085-102B4	29.39	16.03	5.34	10.69	0.00	0.00	0.00	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	49.22	12.55	14.54	12.55	1.98	0.66	0.99	7.60	1.32	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	110.22	16.35	8.86	44.44	2.37	0.25	0.50	2.37	11.11	2.00
breast, adult, donor1	10080-102A8	181.20	111.75	241.18	12.63	3.16	1.26	8.84	2.53	4.42	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.16	4.07	0.89	6.99	0.51	1.02	0.13	0.38	1.78	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.57	7.42	2.78	12.99	1.55	0.00	0.93	2.16	2.16	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	21.41	12.66	3.91	13.81	2.99	0.92	1.15	2.53	3.22	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	32.44	5.08	3.15	12.59	3.87	2.91	1.21	0.73	1.94	1.45
carcinoid cell line:NCI-H1770	10703-109H1	0.47	0.47	0.94	0.00	0.00	0.00	0.00	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	46.49	4.48	2.41	18.59	5.47	0.00	0.44	1.09	1.75	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	38.03	28.84	13.94	12.04	1.90	0.00	1.90	4.12	1.27	2.22
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.29	5.59	5.32	17.04	1.60	0.00	0.80	2.66	1.33	0.80
caudate nucleus - adult, donor10196	10177-103C6	31.09	8.06	24.18	10.36	0.00	0.00	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	15.23	3.35	8.37	2.34	0.84	0.50	0.84	1.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	12.23	3.06	2.29	1.53	0.76	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.45	3.66	4.76	1.10	0.37	0.00	0.00	1.83	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	8.74	0.00	5.83	5.83	0.00	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	31.60	3.42	13.45	15.37	1.92	0.21	0.64	1.07	1.07	0.21
cerebellum, adult, pool1	10083-102B2	13.45	0.69	4.14	3.10	0.69	1.03	0.69	0.69	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	61.44	12.45	24.08	19.10	1.66	0.00	0.83	4.15	5.81	1.66
cerebral meninges, adult	10188-103D8	38.07	7.06	21.94	4.29	1.26	2.77	1.26	1.26	0.50	1.01
cerebrospinal fluid, donor2	10294-104G6	41.66	7.31	15.35	5.85	0.73	0.73	1.46	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	8.05	4.74	0.14	7.33	0.86	0.00	0.43	0.14	0.14	0.43
cervical cancer cell line:ME-180	10553-107I4	14.58	2.32	0.50	12.76	2.15	2.82	0.50	0.66	0.99	0.83
cervix, adult, pool1	10013-101C4	349.62	229.61	239.90	31.60	10.92	28.14	17.22	10.71	5.14	14.49
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.47	16.16	8.36	5.57	1.53	1.39	1.67	1.25	0.84	1.95
chondrosarcoma cell line:SW 1353	10700-109G7	49.64	9.14	0.00	7.84	0.00	1.31	0.00	1.31	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	24.48	5.47	3.11	14.04	3.48	1.86	0.87	1.49	0.99	1.37
choriocarcinoma cell line:SCH	10785-110H2	1.60	0.12	0.12	2.22	0.25	4.07	0.37	0.00	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	131.16	34.87	18.74	34.39	20.87	5.22	5.93	8.54	18.97	5.46
chorionic membrane cells, donor1	12238-129G6	18.52	4.27	5.41	9.40	1.14	2.85	0.28	2.56	0.57	0.85
chorionic membrane cells, donor2	12239-129G7	104.90	29.73	25.95	15.81	5.77	32.02	8.95	5.87	5.67	3.68
chorionic membrane cells, donor3	12240-129G8	25.28	13.19	15.94	12.09	1.10	3.30	1.65	5.49	0.55	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.38	0.00	0.19	0.77	0.00	0.00	0.00	0.00	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.50	1.06	0.21	7.18	0.21	0.21	0.21	0.63	1.27	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	34.15	13.87	5.65	18.49	5.91	0.00	1.80	1.28	3.60	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	32.17	10.64	4.60	23.70	3.63	0.24	1.94	2.18	2.42	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	39.09	17.10	4.48	25.65	7.13	1.22	2.04	3.05	5.09	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	74.50	38.28	15.90	29.45	5.01	0.88	2.36	5.30	6.77	3.24
chronic myelogenous leukemia cell line:KU812	10409-106B4	2.61	0.26	0.00	4.69	0.00	0.00	0.00	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	18.52	7.54	8.91	4.34	3.20	0.46	0.46	1.14	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	129.26	93.69	44.59	20.82	17.87	8.85	13.71	6.59	5.21	10.06
colon carcinoma cell line:CACO-2	10513-107D9	62.97	13.91	5.31	13.00	3.11	4.21	2.75	1.65	9.70	2.93
colon carcinoma cell line:COLO-320	10420-106C6	20.52	14.06	0.76	26.23	0.76	0.38	0.00	0.38	7.60	1.14
colon, adult, donor1	10082-102B1	65.45	32.13	38.08	14.28	3.57	3.57	0.00	2.38	2.38	0.00
colon, adult, pool1	10014-101C5	100.35	40.89	36.19	23.85	2.59	5.41	5.76	1.53	1.29	4.35
colon, fetal, donor1	10070-101I7	68.60	82.81	100.73	12.98	0.62	6.18	4.94	8.03	1.85	10.51
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	0.00	0.00	0.00	0.00	0.00	0.15	0.00	0.30	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	0.00	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	23.55	3.21	6.41	5.20	0.77	1.77	0.22	0.22	1.55	0.11
cruciate ligament, donor2	10295-104G7	154.80	59.97	118.33	17.83	2.43	2.43	2.43	4.86	2.43	3.24
diaphragm, fetal, donor1	10069-101I6	98.72	33.71	91.49	4.82	0.80	0.80	1.61	4.01	3.21	2.41
diencephalon, adult	10193-103E4	11.28	3.12	6.24	4.32	1.44	1.20	0.48	0.96	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	2.30	0.69	0.46	5.28	0.46	0.00	0.00	0.46	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.31	5.64	1.03	15.39	5.90	4.87	1.80	0.77	0.77	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	47.42	31.78	12.28	8.18	3.37	9.15	4.57	2.65	1.20	3.37
ductus deferens, adult	10196-103E7	55.32	42.86	54.82	14.45	1.99	18.44	1.99	9.47	1.50	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	144.02	47.53	93.61	14.40	1.44	1.44	0.00	5.76	5.76	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	119.91	36.05	67.68	32.37	2.21	7.36	3.68	7.36	4.41	2.21
dura mater, adult, donor1	10041-101F5	230.50	24.28	23.29	26.18	5.45	6.03	4.13	2.40	2.31	2.64
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	21.10	13.99	2.00	13.77	12.88	0.00	1.55	1.55	2.44	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	48.72	40.12	6.30	35.54	10.89	0.14	5.16	4.01	4.44	2.72
embryonic pancreas cell line:1B2C6	10604-108F1	53.65	16.65	16.03	12.95	3.70	1.23	0.62	0.62	1.85	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	28.15	29.06	13.62	5.15	9.08	0.30	3.33	1.51	0.00	3.63
embryonic pancreas cell line:1C3IKEI	10606-108F3	53.72	26.24	16.05	15.13	4.94	1.23	1.85	1.23	1.23	3.09
embryonic pancreas cell line:2C6	10603-108E9	43.34	32.84	11.82	22.33	1.31	0.00	1.31	1.31	2.63	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	2.68	1.34	0.00	5.36	0.00	0.34	0.00	0.67	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	28.82	12.51	3.99	15.22	4.71	0.72	1.27	2.17	0.72	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.15	0.48	0.32	5.95	0.16	0.00	0.00	0.48	0.80	0.16
epidermoid carcinoma cell line:A431	10426-106D3	34.90	6.00	1.89	22.57	2.78	4.67	1.00	0.78	0.67	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	10.89	2.75	0.77	3.96	0.77	1.43	0.44	0.11	0.33	0.22
epididymis, adult	10197-103E8	113.66	55.26	80.58	15.49	3.98	15.28	6.07	8.16	2.30	6.91
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	56.42	83.56	28.39	6.03	25.55	5.68	32.82	7.45	1.24	11.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	37.75	23.99	12.19	3.93	12.19	0.79	6.69	1.57	1.18	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.91	11.93	6.81	12.19	3.93	0.00	0.39	3.67	2.36	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	35.73	17.03	5.12	18.31	5.61	0.00	1.28	1.77	1.77	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	22.52	11.31	5.38	13.22	2.58	0.00	0.34	1.57	1.46	0.78
esophagus, adult, pool1	10015-101C6	100.55	30.69	44.28	15.29	2.97	14.12	4.46	3.19	1.17	2.97
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	577.96	252.48	168.07	29.81	110.83	35.94	163.93	16.66	3.38	40.58
eye - muscle inferior rectus, donor1	10272-104E2	219.73	43.46	94.17	28.97	4.83	4.83	7.24	24.15	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	98.90	12.63	50.50	12.63	0.00	0.00	0.00	2.10	4.21	4.21
eye - muscle medial, donor2	10299-104H2	202.40	41.67	133.94	22.32	2.98	1.49	1.49	14.88	5.95	4.46
eye - muscle superior, donor2	10297-104G9	191.46	32.10	97.45	17.20	3.44	1.15	2.29	2.29	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	0.00	1.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	70.17	23.39	57.97	10.17	1.27	4.58	1.27	3.81	1.78	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	50.52	33.08	12.82	10.90	3.46	3.46	3.08	2.56	0.77	1.67
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	19.47	8.31	2.85	7.83	1.19	1.19	1.42	1.19	0.71	0.71
frontal lobe, adult, pool1	10040-101F4	22.14	5.44	8.16	3.75	2.16	1.31	1.03	0.66	0.94	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	65.75	24.02	9.01	25.82	2.40	6.91	2.10	7.21	1.20	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.72	17.65	2.29	6.86	4.75	0.91	1.10	0.64	0.18	3.02
gall bladder, adult	10198-103E9	228.40	50.22	104.54	22.45	6.04	11.11	7.24	7.24	3.86	9.17
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.13	2.96	0.21	4.22	0.63	1.27	0.63	0.63	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	16.83	12.38	2.13	11.60	2.90	0.00	1.35	1.16	0.58	1.55
gastric cancer cell line:AZ521	10549-107H9	11.97	5.08	0.66	8.36	5.57	0.00	1.31	0.98	0.66	2.79
gastric cancer cell line:GSS	10560-108A2	14.64	1.83	0.92	5.49	1.83	0.00	0.00	0.92	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	7.77	0.69	0.23	4.80	0.69	0.00	0.23	0.23	0.46	0.46
giant cell carcinoma cell line:LU65	10487-107B1	1.95	0.46	0.34	2.87	0.11	0.00	0.11	0.11	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	62.84	23.51	8.12	20.29	2.24	3.36	0.28	0.84	3.64	2.24
glassy cell carcinoma cell line:HOKUG	10688-109F4	8.23	1.75	1.25	10.23	0.50	0.50	0.25	1.50	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.18	9.71	3.48	10.24	1.27	2.74	1.16	1.37	1.37	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.93	11.24	2.81	10.81	0.84	2.81	0.84	1.40	2.25	1.26
glioblastoma cell line:T98G	10485-107A8	16.22	10.49	2.43	13.24	2.21	0.66	0.88	0.99	0.11	1.10
glioma cell line:GI-1	10413-106B8	33.39	20.21	9.96	9.96	3.81	3.51	2.93	1.17	1.46	2.93
globus pallidus - adult, donor10196	10175-103C4	21.87	0.73	9.48	8.02	0.00	0.00	0.00	0.73	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	44.43	8.06	25.63	5.37	1.46	1.71	1.22	2.93	1.22	0.00
globus pallidus, adult, donor10258	10367-105F7	10.95	1.37	9.58	1.37	1.37	1.37	1.37	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	49.03	9.06	27.71	11.19	1.07	0.00	2.13	2.66	2.66	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	89.92	11.52	17.60	33.28	2.88	6.40	1.92	3.84	3.52	0.64
hIPS +CCl2, biol_rep1	14383-156B9	18.82	7.35	3.21	6.89	2.30	0.92	0.00	5.97	2.30	0.46
hIPS +CCl2, biol_rep2	14384-156C1	16.46	7.32	4.57	5.49	3.20	1.83	0.91	7.32	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	12.88	5.80	0.64	2.58	5.80	0.64	0.00	7.09	3.22	0.64
hIPS, biol_rep1	14380-156B6	18.68	8.62	0.00	12.94	10.06	2.87	0.00	7.19	7.19	1.44
hIPS, biol_rep2	14381-156B7	19.89	10.29	2.74	7.54	6.86	2.74	0.69	9.60	1.37	0.00
hIPS, biol_rep3	14382-156B8	34.21	3.31	9.93	5.52	1.10	0.00	0.00	1.10	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	70.56	16.14	34.98	9.27	2.69	0.90	1.79	3.89	0.90	1.79
heart - pulmonic valve, adult	10206-103F8	67.72	12.81	36.35	8.63	1.57	2.61	2.88	5.75	1.31	0.52
heart - tricuspid valve, adult	10207-103F9	49.13	10.82	22.48	6.66	0.00	0.00	0.83	13.32	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	41.63	14.69	14.08	11.02	6.73	3.67	5.51	2.24	1.43	2.24
heart, adult, diseased, donor1	10051-101G6	31.09	3.83	12.77	5.11	0.43	0.85	0.00	1.28	0.85	0.00
heart, adult, pool1	10016-101C7	57.72	13.11	24.15	4.83	2.53	0.46	1.61	1.38	0.69	1.15
heart, fetal, pool1	10046-101G1	116.54	30.29	47.23	13.96	3.49	2.05	1.85	2.16	2.57	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	72.50	58.62	22.52	11.11	7.10	13.27	6.48	0.93	0.93	3.39
hepatoblastoma cell line:HuH-6	10633-108I3	76.11	41.62	4.76	39.24	4.76	0.00	1.19	1.19	1.19	7.14
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	40.66	10.39	5.75	14.14	3.54	0.00	1.10	2.43	1.77	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	43.69	12.14	5.46	14.20	2.43	0.12	1.46	1.70	0.73	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	44.87	9.50	6.77	14.05	2.93	0.10	1.72	2.93	0.71	1.62
hepatoma cell line:Li-7	10484-107A7	25.13	16.90	3.11	12.23	1.89	0.00	1.00	2.34	0.44	1.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	37.49	15.48	5.63	13.97	1.61	0.80	1.61	2.11	1.91	1.11
hippocampus - adult, donor10196	10169-103B7	33.12	8.52	24.60	16.09	0.00	0.00	1.89	1.89	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	88.58	8.78	44.49	22.25	3.47	1.02	2.04	7.76	2.45	1.63
hippocampus, adult, donor10258	10374-105G5	20.42	6.47	4.98	9.96	2.49	0.50	1.00	2.99	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	19.39	6.70	12.69	7.05	1.06	0.00	1.41	1.06	1.06	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	0.00	0.20	0.00	0.00	0.00	0.00	0.00	0.20	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	177.62	99.80	37.22	56.95	28.76	5.07	25.94	15.79	15.79	50.75
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	226.71	170.16	83.66	67.39	27.89	5.94	46.48	32.79	18.85	89.60
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	141.21	79.72	26.57	40.24	36.82	3.80	32.65	15.18	17.08	45.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	156.20	77.08	42.92	32.99	24.82	9.93	25.11	10.51	8.17	43.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	156.19	110.51	57.95	28.22	25.42	7.54	31.88	10.56	7.76	55.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	113.44	63.81	23.77	26.69	26.69	8.34	16.68	7.09	7.92	29.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	92.11	47.12	16.34	22.26	27.70	9.95	23.92	5.68	3.08	18.94
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	136.93	77.47	46.77	21.86	37.45	12.38	36.00	10.29	2.57	36.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	103.69	39.72	20.87	21.55	33.67	10.77	21.55	2.69	2.02	14.14
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	0.00	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.00	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	254.10	210.96	69.87	72.55	42.95	8.02	51.35	25.77	10.50	89.16
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	210.62	207.13	61.92	77.62	23.55	12.21	46.66	22.68	13.52	73.70
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	230.39	209.40	90.46	99.45	27.49	12.49	37.98	24.99	20.49	76.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	173.89	133.76	74.23	35.23	12.81	3.39	29.95	12.62	5.27	55.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	199.62	156.88	89.12	44.56	12.73	3.64	35.92	14.55	7.28	61.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	170.09	92.09	60.14	39.15	10.02	4.70	16.91	11.59	6.89	38.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	131.95	47.68	28.25	29.23	5.55	7.19	9.80	6.04	2.29	13.72
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	113.51	42.97	19.45	23.81	6.39	9.00	11.32	9.00	2.03	13.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	146.17	30.49	20.63	39.46	5.08	7.77	8.07	7.17	3.29	11.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	0.18	0.18	0.00	0.18	0.00	0.00	0.00	0.18	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	0.00	0.00	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	223.22	181.67	107.03	55.28	24.29	17.25	39.08	23.59	9.86	47.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	171.04	148.23	65.57	37.69	20.59	14.89	32.94	14.89	8.24	41.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	172.19	122.26	53.26	49.02	30.26	17.85	32.38	13.92	8.78	35.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	177.37	112.22	69.81	29.48	12.41	7.76	39.82	15.00	4.65	36.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	191.94	160.73	99.62	30.55	23.25	3.32	43.83	7.97	1.99	39.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	60.29	32.84	23.09	9.75	8.21	6.41	16.16	4.62	1.54	10.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	108.65	53.43	42.95	19.17	14.83	10.74	16.62	4.60	3.07	14.83
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	149.17	118.88	49.98	21.20	15.90	6.82	28.02	5.30	6.06	24.23
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	115.27	52.76	30.58	19.49	6.39	10.75	10.08	5.38	2.35	17.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.24	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	0.00	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	158.92	136.00	37.29	45.84	50.73	10.70	54.40	21.39	10.09	52.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	162.66	178.93	84.58	81.33	22.77	55.31	52.05	104.10	3.25	133.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	192.61	138.66	50.63	59.24	37.07	15.89	42.03	30.45	18.20	66.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	152.15	96.87	54.73	32.29	24.08	8.76	29.55	9.30	5.47	44.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	119.42	67.67	40.89	23.52	20.27	6.15	19.54	9.41	4.70	27.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	111.74	57.65	36.65	27.40	18.51	3.20	22.78	13.88	5.69	34.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	130.08	82.34	77.57	22.67	27.45	8.35	26.25	13.13	2.39	27.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	195.96	104.82	42.93	33.04	26.81	13.41	36.43	11.65	4.60	33.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	122.04	47.68	43.91	21.01	14.28	8.35	17.51	9.43	2.42	21.82
immature langerhans cells, donor1	11904-125F5	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	38.61	7.57	14.20	8.23	2.27	1.70	1.42	0.47	1.32	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	7.80	0.65	0.98	9.10	1.63	0.98	0.33	0.00	1.95	0.98
kidney, adult, pool1	10017-101C8	216.78	41.25	60.98	27.74	4.31	5.91	4.31	5.11	8.21	2.10
kidney, fetal, pool1	10045-101F9	519.55	161.70	163.26	51.78	12.38	13.44	9.90	7.00	13.09	5.59
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.56	15.91	7.81	12.50	3.12	2.98	2.27	1.28	0.71	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.13	6.22	3.59	3.46	0.55	0.41	1.11	0.41	0.41	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.29	41.47	24.04	9.17	8.26	24.04	5.14	3.67	1.65	4.77
left atrium, adult, donor1	10079-102A7	120.41	40.86	85.54	11.44	2.72	1.63	2.18	1.63	1.63	3.81
left ventricle, adult, donor1	10078-102A6	63.71	20.23	49.55	2.02	0.51	0.00	1.01	1.01	1.52	1.01
leiomyoblastoma cell line:G-402	10721-110A1	126.41	79.07	26.81	15.87	25.45	44.32	16.96	5.20	2.46	8.76
leiomyoma cell line:10964C	10569-108B2	33.41	24.07	16.88	3.59	7.90	6.83	7.90	6.47	2.87	4.31
leiomyoma cell line:15242A	10570-108B3	21.74	13.59	8.15	5.43	4.35	8.15	2.17	1.09	0.54	1.09
leiomyoma cell line:15425	10571-108B4	33.02	28.17	21.12	6.07	9.23	5.58	7.77	4.13	1.70	3.64
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	6.35	0.00	6.35	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	43.91	12.55	19.87	8.36	4.18	4.18	1.05	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	204.59	95.63	35.89	41.44	12.16	4.49	8.62	7.67	3.54	8.26
liposarcoma cell line:KMLS-1	10782-110G8	25.93	15.78	7.34	7.97	2.97	12.65	1.41	1.72	2.50	0.78
liposarcoma cell line:SW 872	10726-110A6	39.11	47.40	12.18	6.58	13.16	1.71	7.19	1.58	1.10	5.24
liver, adult, pool1	10018-101C9	58.02	10.53	18.80	12.80	0.65	0.32	3.40	1.62	1.30	1.46
liver, fetal, pool1	10086-102B5	30.10	11.29	28.22	1.88	0.94	0.00	1.88	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	35.14	4.96	20.12	9.92	1.46	0.73	1.90	2.77	0.87	0.44
locus coeruleus, adult, donor10252	10165-103B3	50.75	5.91	16.43	7.94	2.77	1.48	0.74	5.17	2.40	0.37
locus coeruleus, adult, donor10258	10375-105G6	35.83	11.57	47.68	7.05	1.13	0.85	0.85	4.51	0.56	1.41
locus coeruleus, newborn, donor10223	10362-105F2	75.71	21.45	40.38	12.62	1.26	0.42	3.79	7.57	5.89	1.68
lung adenocarcinoma cell line:A549	10499-107C4	26.16	6.50	2.08	9.00	2.21	0.55	0.69	0.55	0.55	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	35.16	4.83	1.38	46.19	0.69	5.52	2.76	2.07	6.89	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.52	10.55	4.09	5.93	2.37	0.26	0.40	0.26	0.92	1.32
lung, adult, pool1	10019-101D1	121.79	48.90	55.52	15.59	3.19	0.71	6.62	2.13	1.30	3.66
lung, fetal, donor1	10068-101I5	272.85	128.72	161.83	35.68	8.85	3.42	8.85	10.27	4.57	5.99
lung, right lower lobe, adult, donor1	10075-102A3	103.10	38.49	104.47	14.66	1.83	1.37	8.71	3.67	0.92	4.58
lymph node, adult, donor1	10077-102A5	96.09	44.50	102.25	2.37	0.47	0.47	3.31	5.68	0.95	4.73
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	4.25	3.40	13.59	1.70	6.80	2.55	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	19.98	13.32	17.76	6.22	0.89	0.00	0.44	0.89	0.00	0.44
mature adipocyte, donor2	12232-129F9	45.24	15.98	30.09	8.30	0.83	0.00	1.25	0.42	0.21	0.42
mature adipocyte, donor3	12233-129G1	16.59	6.16	5.69	6.64	0.24	0.24	0.47	0.24	1.42	0.47
mature adipocyte, donor4	12234-129G2	20.00	7.37	7.11	6.58	0.26	0.00	0.26	0.26	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	18.35	1.91	0.24	24.78	3.34	0.00	0.71	0.48	1.91	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	9.02	5.64	3.38	2.26	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	19.68	6.07	9.75	2.21	0.92	0.74	0.92	1.47	0.92	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	14.93	2.54	6.04	0.64	0.95	0.64	0.32	0.32	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	23.46	10.24	27.30	1.71	2.13	0.43	0.00	1.28	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	23.12	7.26	20.59	10.63	0.68	0.84	1.18	3.04	0.17	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	23.56	7.22	12.95	3.40	2.12	0.85	0.85	2.12	1.49	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	5.78	5.78	19.26	0.00	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	86.12	57.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.71	10.77	17.23	5.03	1.79	0.36	1.79	2.51	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	49.97	6.49	16.87	18.82	0.00	0.65	0.00	1.95	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	45.20	6.04	24.15	14.55	1.70	1.39	2.01	3.87	1.55	0.62
medulla oblongata, adult, pool1	10038-101F2	49.55	7.59	9.96	12.24	1.39	1.88	0.98	0.98	1.55	0.65
medulla oblongata, newborn, donor10223	10361-105F1	51.04	10.76	34.72	18.75	1.04	1.39	1.39	8.33	2.78	0.00
medulloblastoma cell line:D283 Med	10838-111E1	77.05	116.24	36.53	28.34	6.86	1.11	2.44	3.54	1.33	12.18
medulloblastoma cell line:ONS-76	10759-110E3	0.00	0.00	0.00	0.00	0.00	0.61	0.00	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	18.69	6.76	1.29	12.65	4.31	0.72	2.01	0.86	1.87	1.87
melanoma cell line:G-361	10465-106H6	11.13	2.99	0.27	12.49	0.27	0.00	0.27	0.27	0.00	1.36
meningioma cell line:HKBMM	10691-109F7	8.68	13.57	7.24	1.81	2.71	0.36	0.90	0.90	0.54	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.88	0.00	0.00	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	17.11	6.48	2.33	15.81	1.04	0.00	0.00	0.78	1.56	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	49.25	33.76	22.25	7.36	6.60	5.37	7.21	8.59	3.38	3.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.36	24.90	16.36	4.00	7.27	4.91	9.45	6.18	0.91	3.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	48.04	30.64	31.47	10.35	3.73	3.73	10.77	15.32	4.56	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	26.41	10.68	7.59	4.50	1.97	0.98	1.26	3.51	1.12	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.27	13.29	12.52	6.16	1.73	2.12	1.35	3.27	0.77	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	6.94	9.02	8.33	0.00	1.39	2.08	1.39	2.08	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	27.98	10.30	5.66	4.63	2.40	2.23	0.86	2.92	0.69	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	58.43	18.75	21.39	6.44	3.57	4.49	3.91	4.83	0.92	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.31	19.90	17.91	7.43	2.92	2.65	2.79	6.23	2.39	1.86
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.23	4.46	3.11	4.86	1.08	1.22	1.35	1.89	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	62.88	21.62	18.21	9.96	5.41	3.56	3.56	8.11	2.85	2.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.04	4.28	4.28	8.56	3.29	0.33	0.99	0.99	0.99	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	64.62	29.20	16.05	9.41	5.12	5.95	3.60	8.30	1.94	2.91
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	106.82	69.47	47.48	16.76	16.41	5.59	14.66	9.43	2.09	5.24
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	54.72	29.81	18.78	6.74	7.35	7.35	8.98	12.66	1.22	2.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	39.18	21.93	9.35	6.11	7.91	8.63	5.75	3.95	2.16	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.59	7.86	6.10	6.21	2.38	1.24	0.52	3.31	0.31	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.62	10.94	5.70	4.79	3.65	4.56	2.74	2.96	1.14	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	62.09	27.69	26.01	3.78	7.13	10.07	4.62	10.91	3.36	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	69.49	30.04	19.13	7.17	5.23	10.31	7.17	8.52	1.05	3.59
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	39.13	18.38	13.57	7.79	4.03	3.24	3.50	4.73	1.14	1.66
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	127.02	46.76	50.07	12.52	9.94	7.00	14.73	4.05	1.47	2.95
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	47.22	23.18	14.88	8.30	9.73	19.46	8.30	3.15	2.58	4.01
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.42	2.95	1.68	5.05	2.11	0.00	0.84	0.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.53	21.92	13.70	10.50	2.74	3.20	5.02	1.83	0.46	4.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	45.27	24.04	20.21	13.05	3.84	2.05	5.37	2.56	2.05	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.83	23.03	20.16	9.42	4.19	4.71	7.07	3.14	3.40	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	41.90	27.11	21.87	7.70	4.93	4.31	5.24	3.70	1.54	3.08
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.48	23.06	20.48	13.65	3.53	4.71	6.83	2.35	1.65	3.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.29	17.60	20.31	8.12	4.06	2.71	10.15	2.03	2.71	3.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	30.65	19.26	18.47	11.79	5.11	5.11	7.07	4.32	1.96	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.61	20.85	21.32	7.88	4.63	3.24	6.49	3.71	2.32	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	144.91	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	46.15	23.07	23.94	11.25	3.46	2.60	7.50	1.44	1.15	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	40.83	22.31	15.39	10.49	3.12	4.24	4.91	2.45	1.12	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	46.15	18.75	19.71	11.30	7.21	2.64	3.61	2.88	1.68	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	54.27	25.67	34.47	22.00	5.13	4.40	6.60	0.73	0.73	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	26.85	15.78	16.45	9.40	4.36	2.69	5.71	2.35	2.01	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	36.84	17.19	19.65	7.37	4.91	2.46	6.96	2.87	2.46	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.94	18.47	18.47	12.03	5.15	0.86	7.73	0.86	2.15	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	16.41	30.08	19.14	8.20	2.73	10.94	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	25.82	0.00	0.00	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	23.71	14.62	16.89	7.47	1.62	1.95	3.57	2.60	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	23.28	26.19	18.91	0.00	2.91	7.27	1.45	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	35.72	23.99	33.58	7.46	3.20	2.67	5.86	2.13	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	21.26	16.36	11.45	3.27	2.45	4.09	4.09	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.54	16.33	22.93	5.83	2.72	2.33	6.61	1.94	1.94	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	20.99	10.49	8.39	6.30	0.00	4.20	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	20.86	23.84	8.94	1.99	6.95	4.97	4.97	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	38.14	0.00	4.77	0.00	4.77	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.72	24.31	23.13	12.45	5.34	2.37	5.93	4.74	1.78	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	29.24	21.93	23.15	7.31	2.44	2.44	4.87	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	54.10	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.30	23.44	20.27	9.50	5.70	1.90	3.17	2.53	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.35	20.00	23.11	8.28	2.41	2.41	5.52	2.07	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	12.90	23.64	8.60	0.00	4.30	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	19.96	19.96	11.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	20.66	24.11	3.44	3.44	0.00	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.45	11.41	16.30	5.70	1.22	2.04	1.22	2.04	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	10.33	15.89	6.36	0.79	0.00	3.18	2.38	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	13.56	17.10	5.90	1.18	0.00	1.77	1.77	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.95	9.97	13.71	9.04	0.00	0.62	0.31	0.94	1.25	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	12.03	20.05	9.36	2.67	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	9.46	20.11	4.73	0.00	0.00	0.00	1.18	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	10.27	30.82	10.27	0.00	2.57	0.00	5.14	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.14	8.95	18.59	8.95	2.07	1.38	1.38	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.90	5.94	26.72	2.47	0.99	0.00	0.49	0.00	1.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	7.85	38.13	3.36	0.00	0.00	1.12	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.81	7.00	31.17	2.54	0.64	0.00	0.64	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.85	2.82	19.34	2.01	0.40	0.40	0.81	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	6.54	28.35	0.00	0.00	0.00	0.00	6.54	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	5.07	21.54	6.34	0.00	0.00	0.00	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	3.03	16.99	3.03	0.61	0.00	0.00	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	9.04	45.19	9.04	0.00	0.00	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	7.41	28.01	9.06	0.00	0.00	0.82	1.65	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.42	10.91	10.52	7.34	0.40	0.60	0.79	0.40	0.60	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.47	8.11	14.93	7.14	1.30	0.65	0.97	0.65	0.65	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	5.09	22.41	6.11	0.00	2.04	0.00	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	168.67	17.80	36.36	15.47	6.19	0.00	3.87	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	34.96	15.59	3.07	20.55	4.96	2.13	0.47	2.13	1.42	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.84	2.78	1.85	10.19	1.39	0.23	0.46	0.46	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	34.19	34.19	17.09	12.82	8.55	12.82	12.82	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	64.01	37.20	27.23	11.10	4.32	11.82	4.83	4.83	2.47	3.60
mesothelioma cell line:Mero-25	10850-111F4	58.10	25.42	19.97	12.48	5.90	18.84	3.86	2.72	1.82	1.59
mesothelioma cell line:Mero-41	10851-111F5	27.14	8.56	7.09	10.76	0.73	5.13	0.00	1.47	0.49	0.98
mesothelioma cell line:Mero-48a	10852-111F6	27.01	8.19	4.21	13.73	3.32	5.09	0.66	1.33	2.21	0.89
mesothelioma cell line:Mero-82	10853-111F7	52.82	28.12	26.28	11.30	6.04	7.36	3.42	6.31	2.37	3.94
mesothelioma cell line:Mero-83	10854-111F8	54.47	36.43	24.51	14.47	3.92	8.85	4.60	3.40	1.53	3.23
mesothelioma cell line:Mero-84	10855-111F9	2.53	0.51	0.00	5.06	0.25	0.00	0.00	0.00	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	44.31	9.52	7.04	16.77	4.35	4.97	1.24	1.66	3.93	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	40.25	20.21	15.57	8.94	6.13	4.64	2.82	3.48	5.30	1.33
mesothelioma cell line:NCI-H226	10846-111E9	30.77	23.53	11.76	10.32	9.05	3.98	5.97	3.08	1.63	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	53.64	17.08	16.91	19.47	2.73	7.52	2.90	3.07	2.22	1.37
mesothelioma cell line:NCI-H28	10845-111E8	40.97	8.91	10.94	17.30	1.02	3.05	2.04	3.31	2.29	2.29
mesothelioma cell line:No36	10857-111G2	18.59	9.46	3.91	5.55	1.96	1.63	1.30	0.98	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	53.65	29.53	27.91	19.24	7.04	4.61	4.34	5.42	4.61	3.25
migratory langerhans cells, donor1	11901-125F2	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	0.18	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	5.55	2.61	1.63	2.29	0.98	0.65	0.33	1.63	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.50	10.60	6.99	10.60	1.27	0.85	1.06	1.70	0.21	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	52.06	26.95	10.37	14.51	4.15	2.76	0.69	0.69	1.61	2.76
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2.09	1.33	0.76	2.09	0.19	0.00	0.00	0.19	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	136.97	75.59	86.75	20.29	10.65	4.57	1.01	6.59	2.54	4.06
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.55	1.57	0.59	8.63	0.98	0.39	0.00	0.59	2.16	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.01	1.00	0.45	3.23	0.45	0.33	0.00	0.22	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.75	0.96	0.44	5.22	0.96	0.07	0.00	0.15	0.00	0.29
nasal epithelial cells, donor2	12227-129F4	25.39	9.38	2.76	8.83	6.07	3.31	0.55	34.22	3.31	0.00
neuroblastoma cell line:CHP-134	10508-107D4	8.05	4.60	0.00	14.95	1.15	0.00	0.46	0.46	1.15	0.69
neuroblastoma cell line:NB-1	10539-107G8	32.55	12.35	1.68	31.06	0.56	0.00	0.94	0.75	2.06	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	46.82	22.35	2.74	21.30	1.69	0.42	1.48	2.74	3.16	3.16
neuroblastoma cell line:NH-12	10555-107I6	25.34	14.16	1.86	26.09	1.86	0.00	0.75	1.30	2.61	2.61
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.33	28.23	18.27	15.89	3.80	0.00	0.95	1.19	2.37	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	105.32	54.32	44.66	33.89	4.12	1.11	3.01	10.14	5.23	7.13
neuroectodermal tumor cell line:TASK1	10774-110F9	21.33	12.68	4.43	12.28	0.40	0.20	0.40	1.01	1.21	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	11.44	1.27	17.17	0.00	0.64	1.27	0.64	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	125.90	61.22	40.99	14.91	11.71	20.76	10.38	5.86	4.26	2.93
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	0.80	0.00	4.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.28	10.58	8.02	12.82	1.60	4.49	0.32	1.92	0.96	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.09	2.36	1.58	3.42	0.00	0.53	0.53	0.26	1.31	0.53
nucleus accumbens, adult, pool1	10037-101F1	24.65	5.06	8.34	3.94	1.22	0.84	0.47	0.19	0.84	0.37
occipital cortex - adult, donor10196	10172-103C1	12.36	6.18	8.24	2.06	0.00	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	19.86	4.03	9.39	5.10	1.61	0.00	0.54	1.61	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	20.02	8.37	13.83	2.91	1.46	0.00	1.46	1.46	0.36	1.09
occipital lobe, adult, donor1	10076-102A4	20.73	4.99	13.91	3.67	1.31	1.31	1.31	0.26	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	44.63	20.17	40.34	6.01	1.29	0.86	1.29	2.57	0.86	2.57
occipital pole, adult, pool1	10036-101E9	19.00	3.15	3.55	2.84	0.55	0.39	0.24	0.32	0.63	0.32
olfactory region, adult	10195-103E6	15.09	5.73	12.42	2.10	0.38	0.57	0.00	0.57	0.38	0.57
optic nerve, donor1	10277-104E7	50.03	14.01	26.01	4.00	0.00	2.00	2.00	4.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.78	4.10	0.91	28.48	1.71	2.73	1.37	1.94	2.62	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	41.08	15.25	3.30	18.55	2.06	3.30	0.14	1.79	2.61	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.87	4.23	2.88	9.14	1.19	6.43	0.68	0.68	1.35	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	26.80	8.89	3.12	16.63	3.70	6.24	1.73	1.73	2.43	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	7.06	5.59	1.18	7.35	0.88	0.59	0.59	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	55.13	12.15	1.87	26.16	7.47	0.93	2.80	4.67	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	23.75	4.88	1.27	14.00	0.85	0.21	1.27	0.85	0.00	0.21
ovary, adult, pool1	10020-101D2	417.10	174.35	228.95	24.81	13.02	12.49	20.88	7.42	7.16	11.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.42	12.47	2.75	8.07	1.65	1.47	0.92	0.55	1.10	0.73
pancreas, adult, donor1	10049-101G4	28.22	6.58	15.99	10.35	0.94	0.00	0.94	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	15.09	5.87	1.68	10.06	3.35	1.68	1.12	1.96	0.84	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	35.43	14.48	12.95	11.92	4.09	8.86	1.36	3.75	1.53	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	87.10	38.42	13.91	21.19	4.14	5.46	2.65	2.48	4.64	3.64
paracentral gyrus, adult, pool1	10035-101E8	18.40	5.31	6.96	3.11	0.55	0.64	0.64	0.37	0.64	0.18
parietal cortex, adult, donor10258	10373-105G4	27.89	7.34	16.15	3.67	0.73	1.47	0.00	41.84	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	10.35	1.88	7.52	3.76	0.94	0.00	0.94	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	16.25	3.99	8.27	1.43	2.00	0.29	0.29	1.14	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	16.57	3.79	6.34	3.08	0.88	1.32	0.53	0.53	0.53	0.35
parietal lobe, fetal, donor1	10072-101I9	79.53	34.91	45.58	9.70	1.94	0.00	0.97	4.85	0.97	6.79
parietal lobe, newborn, donor10223	10356-105E5	19.07	5.61	16.08	2.62	1.50	1.12	0.75	1.87	0.75	0.37
parotid gland, adult	10199-103F1	22.20	3.08	11.10	9.25	0.00	0.00	0.00	1.85	3.08	0.62
penis, adult	10200-103F2	158.99	58.01	123.54	11.28	3.22	23.10	5.91	9.67	1.07	7.52
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	63.78	167.90	97.99	6.69	9.30	0.00	18.04	13.02	0.37	18.97
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.84	7.58	4.37	14.57	2.04	12.97	0.87	2.62	1.75	0.73
pineal gland - adult, donor10196	10179-103C8	18.06	1.29	8.39	8.39	0.00	0.65	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	45.60	7.11	9.48	13.62	0.59	0.00	0.00	0.59	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	22.57	1.88	7.52	4.39	0.63	0.00	0.00	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	42.50	11.13	14.17	28.33	0.00	3.04	0.00	1.01	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	83.39	11.99	22.41	55.25	0.52	2.08	1.04	1.04	4.69	1.04
pituitary gland, adult, donor10258	10378-105G9	29.79	5.11	11.92	15.32	1.70	0.85	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	89.87	25.37	26.98	10.64	6.02	6.56	4.09	2.26	2.80	1.72
plasma cell leukemia cell line:ARH-77	10840-111E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	10.89	3.11	2.18	7.32	0.47	0.31	0.47	0.16	0.16	0.62
pons, adult, pool1	10033-101E6	25.13	3.18	6.20	5.77	1.12	0.60	0.43	0.09	1.20	0.34
postcentral gyrus, adult, pool1	10032-101E5	19.35	3.57	6.45	3.40	0.96	0.70	0.35	0.61	0.44	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	28.40	21.56	7.14	9.76	2.77	0.58	0.58	1.02	1.46	1.17
prostate cancer cell line:PC-3	10439-106E7	41.02	66.61	13.25	9.44	3.63	1.27	3.63	1.63	1.09	3.99
prostate, adult, pool1	10022-101D4	106.38	55.41	48.07	19.41	4.17	10.79	4.63	4.17	2.45	3.54
putamen, adult, donor10196	10176-103C5	6.14	0.24	0.94	0.94	0.24	0.24	0.00	0.24	0.00	0.00
putamen, adult, donor10252	10152-102I8	19.61	5.88	9.80	1.96	0.00	0.00	0.00	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	13.11	3.28	1.09	3.28	2.19	2.19	2.19	2.19	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.63	1.93	2.42	2.17	0.72	0.48	0.48	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	43.48	14.24	16.49	3.75	0.75	0.75	2.25	3.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	94.26	54.40	9.60	21.53	11.35	21.53	4.65	4.95	4.65	4.65
rectum, fetal, donor1	10067-101I4	116.84	70.94	158.57	8.35	4.17	8.35	1.39	1.39	1.39	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	72.08	26.50	15.05	19.50	3.60	3.60	2.33	3.39	4.66	2.12
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	31.07	47.63	8.28	11.18	2.90	1.24	5.80	1.66	1.24	3.31
retina, adult, pool1	10030-101E3	192.14	33.10	59.74	29.52	4.27	13.92	2.09	2.58	5.07	1.69
retinoblastoma cell line:Y79	10475-106I7	7.01	4.68	0.52	11.95	0.52	0.00	0.52	0.26	1.30	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	57.42	65.41	14.63	9.34	16.11	4.79	18.57	6.76	2.58	5.66
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	48.09	26.43	2.25	29.53	4.78	0.28	0.84	2.81	3.66	3.66
sacrococcigeal teratoma cell line:HTST	10695-109G2	24.25	40.17	9.85	10.61	2.27	0.76	3.03	2.27	0.76	3.79
salivary acinar cells, donor1	11771-123I7	11.98	3.24	2.27	10.04	0.81	0.16	0.49	0.32	0.49	0.32
salivary acinar cells, donor2	11772-123I8	15.42	6.20	5.92	12.67	1.51	0.28	0.83	0.55	0.83	0.28
salivary acinar cells, donor3	11773-123I9	27.14	9.93	7.94	17.88	3.31	0.00	0.66	0.00	2.65	1.32
salivary gland, adult, pool1	10093-102C3	21.73	5.72	9.15	12.01	0.57	1.72	0.57	1.72	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	21.92	12.23	3.79	7.17	2.02	0.93	2.19	0.93	0.42	1.60
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.10	12.81	3.64	6.47	1.53	1.18	1.53	0.94	0.24	1.88
seminal vesicle, adult	10201-103F3	103.70	88.35	80.95	23.81	3.17	33.33	7.94	13.23	2.65	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	28.18	7.04	6.32	10.20	1.21	8.02	0.00	2.19	1.21	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	3.27	3.02	3.77	1.76	0.25	0.00	0.00	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	1.00	3.01	11.04	2.01	0.00	0.00	1.00	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	81.40	13.84	15.31	12.63	3.49	1.21	0.67	5.24	4.57	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	16.14	5.42	0.66	8.73	1.99	0.00	0.11	1.44	0.55	1.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.87	5.68	1.68	14.19	0.52	0.13	0.26	0.39	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	84.41	24.12	34.76	9.22	0.71	1.42	2.84	5.67	0.71	2.84
skeletal muscle, adult, pool1	10023-101D5	96.31	15.71	29.50	9.00	1.32	2.16	3.12	1.32	1.56	2.16
skeletal muscle, fetal, donor1	10066-101I3	68.34	29.15	80.40	14.07	0.00	1.01	3.02	3.02	1.01	2.01
skin, adult, donor1	10074-102A2	33.93	27.14	27.14	20.36	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	96.58	22.72	51.13	11.99	1.26	3.16	0.00	1.26	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	3.34	1.67	0.00	4.34	0.67	0.00	0.00	0.33	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	113.16	63.36	27.11	58.00	8.20	0.00	2.21	4.41	1.26	5.36
small cell lung carcinoma cell line:DMS 144	10841-111E4	376.05	212.02	218.77	17.93	82.11	2.12	65.53	21.59	6.94	24.67
small cell lung carcinoma cell line:LK-2	10541-107H1	16.98	6.26	0.16	16.81	3.63	0.16	1.15	0.49	2.80	2.47
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.15	6.11	1.29	3.86	0.80	0.00	0.00	0.16	0.16	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	67.55	24.62	15.69	20.05	5.45	0.44	1.96	3.70	3.05	1.96
small intestine, adult, pool1	10024-101D6	51.96	14.57	13.26	23.05	1.07	3.22	2.63	1.19	1.07	2.63
small intestine, fetal, donor1	10064-101I1	58.48	25.31	42.75	15.72	1.23	2.46	0.74	4.18	0.98	3.19
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.24	7.69	5.64	24.11	1.54	0.00	0.00	1.54	1.54	1.54
smooth muscle, adult, pool1	10048-101G3	72.63	25.59	37.48	10.60	1.03	8.27	1.03	3.36	0.78	2.33
somatostatinoma cell line:QGP-1	10781-110G7	9.38	3.22	0.54	20.64	0.00	0.00	0.00	0.00	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	59.87	11.70	45.19	10.32	0.69	3.44	1.15	0.92	1.15	0.46
spinal cord, adult, donor10252	10159-103A6	53.23	9.46	23.66	17.35	2.76	1.18	0.39	0.79	1.97	0.79
spinal cord, adult, donor10258	10369-105F9	56.73	17.29	40.12	21.45	0.69	3.46	0.00	4.15	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	133.55	37.20	88.43	23.17	1.22	7.93	2.44	1.83	2.44	1.83
spinal cord, newborn, donor10223	10359-105E8	51.43	11.94	29.85	16.07	1.38	3.21	1.84	6.43	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.82	16.43	5.82	13.29	4.78	2.99	2.54	0.60	2.09	1.49
spleen, adult, pool1	10025-101D7	288.66	73.35	144.94	20.48	4.63	3.41	10.13	5.84	9.36	5.07
spleen, fetal, pool1	10044-101F8	385.52	101.94	167.33	23.52	7.87	3.26	7.71	7.63	7.55	4.05
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	3.00	0.31	0.21	3.42	0.21	0.00	0.00	0.10	0.52	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.94	0.76	0.00	5.13	0.57	0.00	0.38	0.57	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	54.51	25.51	14.68	16.42	12.58	9.78	4.89	4.54	2.45	4.89
squamous cell carcinoma cell line:T3M-5	10616-108G4	49.65	16.42	17.20	9.38	4.30	5.47	0.78	1.17	2.74	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.18	1.01	0.45	5.52	0.56	0.00	0.11	0.79	0.34	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.39	0.42	0.00	4.66	0.42	0.00	0.00	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	31.73	8.04	5.50	5.50	3.38	8.04	0.00	1.27	0.42	0.85
stomach, fetal, donor1	10062-101H8	405.83	96.12	169.81	44.85	3.20	5.34	3.20	4.27	3.20	4.27
submaxillary gland, adult	10202-103F4	39.88	8.55	20.51	6.84	0.57	1.14	0.57	1.71	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	434.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	43.83	10.39	27.83	9.35	0.83	1.25	0.42	4.98	1.45	0.00
substantia nigra, adult, donor10258	10371-105G2	48.10	6.21	11.38	10.86	5.17	0.00	0.52	4.66	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	65.00	12.01	37.45	15.54	1.41	0.00	3.53	4.24	3.53	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	119.91	113.03	16.51	33.24	20.86	6.88	20.86	6.42	5.96	13.99
temporal lobe, adult, pool1	10031-101E4	32.21	5.76	8.31	8.65	1.61	0.93	1.44	0.68	0.42	1.36
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	163.82	103.99	108.26	34.90	3.56	0.71	2.14	5.70	2.85	12.11
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	107.25	46.59	65.93	20.66	3.52	1.76	2.64	12.31	3.08	9.23
tenocyte, donor1	11763-123H8	9.43	3.84	6.28	2.44	1.40	0.00	0.70	2.44	0.35	0.35
tenocyte, donor2	11765-123I1	9.92	3.43	7.25	1.14	0.00	0.76	0.38	1.53	1.14	0.38
tenocyte, donor3	11768-123I4	14.83	9.64	9.27	7.41	2.97	1.85	0.37	2.59	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.57	0.51	0.34	1.19	0.00	0.00	0.00	0.34	0.51	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	0.46	0.31	0.15	1.08	0.15	0.00	0.00	0.00	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	0.00	0.00	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1.14	0.13	0.00	1.02	0.00	0.63	0.00	0.13	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.65	0.55	0.22	0.55	0.33	0.22	0.11	0.55	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.33	0.33	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	192.09	93.84	122.40	17.18	4.72	13.31	16.54	5.15	2.68	10.31
testis, adult, pool2	10096-102C6	99.69	36.54	72.62	11.28	3.16	14.89	3.61	13.98	4.06	1.80
thalamus - adult, donor10196	10168-103B6	49.68	9.94	26.50	13.25	2.21	2.21	2.21	3.31	2.21	0.00
thalamus, adult, donor10252	10154-103A1	33.13	3.75	15.00	9.22	1.25	0.78	0.47	2.50	1.88	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	4.62	7.70	33.87	0.00	3.08	0.00	1.54	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	34.26	4.94	19.76	9.22	0.33	0.33	0.66	2.80	1.15	1.32
thalamus, newborn, donor10223	10366-105F6	51.20	21.29	29.34	7.48	3.45	0.58	4.60	9.21	1.73	2.30
throat, adult	10209-103G2	79.39	17.98	47.44	12.48	1.75	0.25	2.25	1.75	0.75	3.00
throat, fetal, donor1	10061-101H7	87.15	41.14	91.11	14.02	0.91	2.44	2.44	5.79	1.22	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	254.38	251.00	202.51	31.80	10.93	4.57	17.89	15.90	19.87	8.55
thymus, adult, pool1	10027-101D9	9.84	1.39	2.29	2.19	0.30	0.00	0.40	0.10	0.20	0.00
thymus, fetal, pool1	10043-101F7	43.85	11.64	16.83	6.23	0.83	0.73	1.14	0.73	1.35	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	17.28	9.31	5.32	5.32	1.33	2.66	0.53	0.80	0.80	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	66.35	41.77	25.00	14.11	4.47	11.18	3.49	2.51	1.12	5.73
thyroid, adult, pool1	10028-101E1	100.12	23.05	44.42	17.54	1.87	0.93	3.17	1.96	3.08	1.68
thyroid, fetal, donor1	10060-101H6	76.20	20.57	76.73	7.91	0.53	0.53	0.53	2.90	2.37	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	258.69	27.72	86.23	15.40	0.00	0.00	0.00	12.32	6.16	3.08
tongue, adult	10203-103F5	57.68	8.37	50.24	8.61	0.70	2.79	1.16	1.63	0.47	0.93
tongue, fetal, donor1	10059-101H5	78.03	27.19	69.75	8.28	1.18	3.55	0.79	3.55	2.36	1.58
tonsil, adult, pool1	10047-101G2	51.59	8.31	12.52	6.81	0.80	0.90	0.50	1.30	0.90	0.70
trachea, adult, pool1	10029-101E2	131.04	21.19	30.27	20.12	2.13	4.01	3.11	1.55	5.32	1.64
trachea, fetal, donor1	10058-101H4	100.79	37.32	90.40	11.93	1.92	6.92	4.23	5.00	2.31	3.46
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	37.20	34.72	16.30	7.09	3.54	4.96	3.19	2.83	2.13	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	31.31	13.07	3.85	12.87	2.53	5.88	0.91	0.51	2.63	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.80	19.59	13.16	8.30	1.88	2.19	2.04	2.04	0.47	1.41
tridermal teratoma cell line:HGRT	10694-109G1	190.25	97.03	62.78	20.93	5.71	1.90	5.71	9.51	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	43.51	25.48	8.04	8.21	2.88	9.57	1.86	0.68	0.51	2.29
umbilical cord, fetal, donor1	10057-101H3	47.99	10.43	41.73	2.09	0.00	4.17	0.00	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	329.31	177.11	154.76	34.81	10.24	35.15	8.36	21.16	5.12	5.80
uterus, fetal, donor1	10055-101H1	213.47	218.59	258.52	11.77	7.68	26.62	10.24	15.36	2.56	7.17
vagina, adult	10204-103F6	109.21	49.11	87.88	15.51	3.23	1.29	3.23	10.99	2.58	4.52
vein, adult	10191-103E2	90.97	20.60	67.73	9.43	1.10	1.32	3.29	2.63	2.19	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.60	0.27	0.00	1.34	0.00	0.53	0.00	0.00	0.27	0.00